CN1407077A - 温和的具有稳定泡沫的清洁组合物 - Google Patents
温和的具有稳定泡沫的清洁组合物 Download PDFInfo
- Publication number
- CN1407077A CN1407077A CN 02131518 CN02131518A CN1407077A CN 1407077 A CN1407077 A CN 1407077A CN 02131518 CN02131518 CN 02131518 CN 02131518 A CN02131518 A CN 02131518A CN 1407077 A CN1407077 A CN 1407077A
- Authority
- CN
- China
- Prior art keywords
- composition
- acid
- composition according
- glucosides
- mixtures
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006260 foam Substances 0.000 title claims abstract description 22
- 239000003599 detergent Substances 0.000 title description 2
- 239000000203 mixture Substances 0.000 claims abstract description 145
- 239000003945 anionic surfactant Substances 0.000 claims abstract description 20
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims abstract description 12
- -1 octyl group glucosides Chemical class 0.000 claims description 65
- 238000004140 cleaning Methods 0.000 claims description 24
- 150000005690 diesters Chemical class 0.000 claims description 13
- 229930182478 glucoside Natural products 0.000 claims description 12
- 150000002148 esters Chemical class 0.000 claims description 8
- 150000008131 glucosides Chemical class 0.000 claims description 8
- 229920000642 polymer Polymers 0.000 claims description 8
- 235000013162 Cocos nucifera Nutrition 0.000 claims description 6
- 244000060011 Cocos nucifera Species 0.000 claims description 6
- 239000013543 active substance Substances 0.000 claims description 3
- 239000012752 auxiliary agent Substances 0.000 claims description 2
- 150000002500 ions Chemical class 0.000 claims description 2
- 235000016068 Berberis vulgaris Nutrition 0.000 claims 2
- 241000335053 Beta vulgaris Species 0.000 claims 2
- 239000012190 activator Substances 0.000 claims 2
- 239000003513 alkali Substances 0.000 claims 2
- 230000000638 stimulation Effects 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 abstract description 19
- 239000002280 amphoteric surfactant Substances 0.000 abstract description 15
- 229930182470 glycoside Natural products 0.000 abstract description 13
- 239000002736 nonionic surfactant Substances 0.000 abstract description 12
- 229960003237 betaine Drugs 0.000 abstract description 11
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 abstract description 10
- 150000002338 glycosides Chemical class 0.000 abstract description 8
- 239000003795 chemical substances by application Substances 0.000 description 26
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 18
- 125000004432 carbon atom Chemical group C* 0.000 description 17
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 15
- 108090000623 proteins and genes Proteins 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- 235000001014 amino acid Nutrition 0.000 description 14
- 229940024606 amino acid Drugs 0.000 description 14
- 150000001413 amino acids Chemical class 0.000 description 14
- 235000018102 proteins Nutrition 0.000 description 14
- 102000004169 proteins and genes Human genes 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 239000002671 adjuvant Substances 0.000 description 13
- 239000000463 material Substances 0.000 description 13
- 239000000126 substance Substances 0.000 description 13
- 125000002091 cationic group Chemical group 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 239000002453 shampoo Substances 0.000 description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 10
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 10
- 229920000289 Polyquaternium Polymers 0.000 description 9
- 125000000217 alkyl group Chemical group 0.000 description 9
- 229920001577 copolymer Polymers 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 9
- 229920005862 polyol Polymers 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- 239000004698 Polyethylene Substances 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 229920000573 polyethylene Polymers 0.000 description 8
- 229940088594 vitamin Drugs 0.000 description 8
- 229930003231 vitamin Natural products 0.000 description 8
- 235000013343 vitamin Nutrition 0.000 description 8
- 239000011782 vitamin Substances 0.000 description 8
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 7
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 7
- 239000003974 emollient agent Substances 0.000 description 7
- 235000011187 glycerol Nutrition 0.000 description 7
- 229920001223 polyethylene glycol Polymers 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 150000005691 triesters Chemical class 0.000 description 7
- 235000019155 vitamin A Nutrition 0.000 description 7
- 239000011719 vitamin A Substances 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 6
- 239000002202 Polyethylene glycol Substances 0.000 description 6
- LWZFANDGMFTDAV-BURFUSLBSA-N [(2r)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O LWZFANDGMFTDAV-BURFUSLBSA-N 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 6
- 229950006451 sorbitan laurate Drugs 0.000 description 6
- 235000011067 sorbitan monolaureate Nutrition 0.000 description 6
- 235000019154 vitamin C Nutrition 0.000 description 6
- 239000011718 vitamin C Substances 0.000 description 6
- 229940045997 vitamin a Drugs 0.000 description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 5
- 229930003268 Vitamin C Natural products 0.000 description 5
- 239000002738 chelating agent Substances 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 150000004665 fatty acids Chemical group 0.000 description 5
- 230000007794 irritation Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 230000000475 sunscreen effect Effects 0.000 description 5
- 239000000516 sunscreening agent Substances 0.000 description 5
- 239000002562 thickening agent Substances 0.000 description 5
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 4
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 4
- 201000004384 Alopecia Diseases 0.000 description 4
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 4
- 206010015946 Eye irritation Diseases 0.000 description 4
- 102000011782 Keratins Human genes 0.000 description 4
- 108010076876 Keratins Proteins 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 235000015165 citric acid Nutrition 0.000 description 4
- 239000007854 depigmenting agent Substances 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 231100000013 eye irritation Toxicity 0.000 description 4
- 230000003779 hair growth Effects 0.000 description 4
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 4
- 239000002480 mineral oil Substances 0.000 description 4
- 235000010446 mineral oil Nutrition 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 4
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 4
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 3
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 3
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 244000007835 Cyamopsis tetragonoloba Species 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 3
- 208000001840 Dandruff Diseases 0.000 description 3
- JDRSMPFHFNXQRB-CMTNHCDUSA-N Decyl beta-D-threo-hexopyranoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)C(O)[C@H](O)C1O JDRSMPFHFNXQRB-CMTNHCDUSA-N 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical group OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
- 240000004670 Glycyrrhiza echinata Species 0.000 description 3
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 3
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 3
- 239000004909 Moisturizer Substances 0.000 description 3
- 229920001213 Polysorbate 20 Polymers 0.000 description 3
- 201000004681 Psoriasis Diseases 0.000 description 3
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 3
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 3
- 229960005084 calcitriol Drugs 0.000 description 3
- 235000020964 calcitriol Nutrition 0.000 description 3
- 239000011612 calcitriol Substances 0.000 description 3
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 3
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 229940073499 decyl glucoside Drugs 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- VEVFSWCSRVJBSM-HOFKKMOUSA-N ethyl 4-[4-[[(2r,4s)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OCC)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 VEVFSWCSRVJBSM-HOFKKMOUSA-N 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 235000013922 glutamic acid Nutrition 0.000 description 3
- 239000004220 glutamic acid Substances 0.000 description 3
- 230000003676 hair loss Effects 0.000 description 3
- 208000024963 hair loss Diseases 0.000 description 3
- 229920001519 homopolymer Polymers 0.000 description 3
- 239000003906 humectant Substances 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 229960004125 ketoconazole Drugs 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 229940010454 licorice Drugs 0.000 description 3
- 229940041616 menthol Drugs 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000001333 moisturizer Effects 0.000 description 3
- 231100000286 mucous membrane, eye irritation or corrosion testing Toxicity 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- 235000001968 nicotinic acid Nutrition 0.000 description 3
- 239000011664 nicotinic acid Substances 0.000 description 3
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 150000003077 polyols Chemical class 0.000 description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 125000001453 quaternary ammonium group Chemical group 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 208000008742 seborrheic dermatitis Diseases 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- 239000011593 sulfur Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- 229960001727 tretinoin Drugs 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 229940011671 vitamin b6 Drugs 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 235000002961 Aloe barbadensis Nutrition 0.000 description 2
- 244000144927 Aloe barbadensis Species 0.000 description 2
- 229930192334 Auxin Natural products 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 240000003538 Chamaemelum nobile Species 0.000 description 2
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 2
- 229930105110 Cyclosporin A Natural products 0.000 description 2
- 108010036949 Cyclosporine Proteins 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
- VZRKEAFHFMSHCD-UHFFFAOYSA-N Ethyl 3-(N-butylacetamido)propionate Chemical group CCCCN(C(C)=O)CCC(=O)OCC VZRKEAFHFMSHCD-UHFFFAOYSA-N 0.000 description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- SHGAZHPCJJPHSC-NUEINMDLSA-N Isotretinoin Chemical compound OC(=O)C=C(C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NUEINMDLSA-N 0.000 description 2
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 2
- 235000000072 L-ascorbyl-6-palmitate Nutrition 0.000 description 2
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- 229920002884 Laureth 4 Polymers 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 2
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 2
- MMOXZBCLCQITDF-UHFFFAOYSA-N N,N-diethyl-m-toluamide Chemical compound CCN(CC)C(=O)C1=CC=CC(C)=C1 MMOXZBCLCQITDF-UHFFFAOYSA-N 0.000 description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
- 239000008118 PEG 6000 Substances 0.000 description 2
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 2
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 2
- 240000002299 Symphytum officinale Species 0.000 description 2
- 235000005865 Symphytum officinale Nutrition 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 229940048053 acrylate Drugs 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000008186 active pharmaceutical agent Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 229920013820 alkyl cellulose Polymers 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- 235000011399 aloe vera Nutrition 0.000 description 2
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 2
- 229940064734 aminobenzoate Drugs 0.000 description 2
- 229960004050 aminobenzoic acid Drugs 0.000 description 2
- 229940035676 analgesics Drugs 0.000 description 2
- 239000000730 antalgic agent Substances 0.000 description 2
- 239000000058 anti acne agent Substances 0.000 description 2
- 230000003656 anti-hair-loss Effects 0.000 description 2
- 230000001166 anti-perspirative effect Effects 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 229940124340 antiacne agent Drugs 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000003213 antiperspirant Substances 0.000 description 2
- 229940064004 antiseptic throat preparations Drugs 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 239000002363 auxin Substances 0.000 description 2
- 229960000686 benzalkonium chloride Drugs 0.000 description 2
- MITFXPHMIHQXPI-UHFFFAOYSA-N benzoxaprofen Natural products N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=C(Cl)C=C1 MITFXPHMIHQXPI-UHFFFAOYSA-N 0.000 description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
- 150000001277 beta hydroxy acids Chemical class 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 229960002537 betamethasone Drugs 0.000 description 2
- UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 description 2
- VEMKTZHHVJILDY-UXHICEINSA-N bioresmethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-UXHICEINSA-N 0.000 description 2
- 229960005074 butoconazole Drugs 0.000 description 2
- SWLMUYACZKCSHZ-UHFFFAOYSA-N butoconazole Chemical compound C1=CC(Cl)=CC=C1CCC(SC=1C(=CC=CC=1Cl)Cl)CN1C=NC=C1 SWLMUYACZKCSHZ-UHFFFAOYSA-N 0.000 description 2
- GMRQFYUYWCNGIN-NKMMMXOESA-N calcitriol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-NKMMMXOESA-N 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- 229930008380 camphor Natural products 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 229960001265 ciclosporin Drugs 0.000 description 2
- 239000012459 cleaning agent Substances 0.000 description 2
- KNHUKKLJHYUCFP-UHFFFAOYSA-N clofibrate Chemical compound CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 KNHUKKLJHYUCFP-UHFFFAOYSA-N 0.000 description 2
- 229960001214 clofibrate Drugs 0.000 description 2
- 229940071160 cocoate Drugs 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 229920013750 conditioning polymer Polymers 0.000 description 2
- 239000003246 corticosteroid Substances 0.000 description 2
- 229960001334 corticosteroids Drugs 0.000 description 2
- YPHMISFOHDHNIV-FSZOTQKASA-N cycloheximide Chemical compound C1[C@@H](C)C[C@H](C)C(=O)[C@@H]1[C@H](O)CC1CC(=O)NC(=O)C1 YPHMISFOHDHNIV-FSZOTQKASA-N 0.000 description 2
- 229930182912 cyclosporin Natural products 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- 230000002939 deleterious effect Effects 0.000 description 2
- 239000002781 deodorant agent Substances 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- HSUGRBWQSSZJOP-RTWAWAEBSA-N diltiazem Chemical compound C1=CC(OC)=CC=C1[C@H]1[C@@H](OC(C)=O)C(=O)N(CCN(C)C)C2=CC=CC=C2S1 HSUGRBWQSSZJOP-RTWAWAEBSA-N 0.000 description 2
- 229960004166 diltiazem Drugs 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- YIOJGTBNHQAVBO-UHFFFAOYSA-N dimethyl-bis(prop-2-enyl)azanium Chemical compound C=CC[N+](C)(C)CC=C YIOJGTBNHQAVBO-UHFFFAOYSA-N 0.000 description 2
- QKQCPXJIOJLHAL-UHFFFAOYSA-L disodium;2-[2-(carboxylatomethoxy)ethyl-[2-(dodecanoylamino)ethyl]amino]acetate Chemical compound [Na+].[Na+].CCCCCCCCCCCC(=O)NCCN(CC([O-])=O)CCOCC([O-])=O QKQCPXJIOJLHAL-UHFFFAOYSA-L 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229960003276 erythromycin Drugs 0.000 description 2
- AEUTYOVWOVBAKS-UWVGGRQHSA-N ethambutol Chemical compound CC[C@@H](CO)NCCN[C@@H](CC)CO AEUTYOVWOVBAKS-UWVGGRQHSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 229960004884 fluconazole Drugs 0.000 description 2
- RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229940074046 glyceryl laurate Drugs 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 description 2
- 229940091173 hydantoin Drugs 0.000 description 2
- 229960000890 hydrocortisone Drugs 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- ROBFUDYVXSDBQM-UHFFFAOYSA-N hydroxymalonic acid Chemical compound OC(=O)C(O)C(O)=O ROBFUDYVXSDBQM-UHFFFAOYSA-N 0.000 description 2
- 150000002460 imidazoles Chemical class 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 239000002917 insecticide Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical class OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- 229960005280 isotretinoin Drugs 0.000 description 2
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 2
- 229960004705 kojic acid Drugs 0.000 description 2
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 2
- 229940061515 laureth-4 Drugs 0.000 description 2
- 239000003589 local anesthetic agent Substances 0.000 description 2
- 229960005015 local anesthetics Drugs 0.000 description 2
- 235000018977 lysine Nutrition 0.000 description 2
- 229960001047 methyl salicylate Drugs 0.000 description 2
- 229960002509 miconazole Drugs 0.000 description 2
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 2
- 229960001597 nifedipine Drugs 0.000 description 2
- 229940049964 oleate Drugs 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 239000003605 opacifier Substances 0.000 description 2
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 2
- 229960001173 oxybenzone Drugs 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 229960003742 phenol Drugs 0.000 description 2
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920001515 polyalkylene glycol Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 150000007519 polyprotic acids Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 229940068977 polysorbate 20 Drugs 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 2
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 2
- ARIWANIATODDMH-UHFFFAOYSA-N rac-1-monolauroylglycerol Chemical compound CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 229930002330 retinoic acid Natural products 0.000 description 2
- 229960003471 retinol Drugs 0.000 description 2
- 235000020944 retinol Nutrition 0.000 description 2
- 239000011607 retinol Substances 0.000 description 2
- 229940108325 retinyl palmitate Drugs 0.000 description 2
- 235000019172 retinyl palmitate Nutrition 0.000 description 2
- 239000011769 retinyl palmitate Substances 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- VIDTVPHHDGRGAF-UHFFFAOYSA-N selenium sulfide Chemical compound [Se]=S VIDTVPHHDGRGAF-UHFFFAOYSA-N 0.000 description 2
- 229960005265 selenium sulfide Drugs 0.000 description 2
- 235000004400 serine Nutrition 0.000 description 2
- 239000003079 shale oil Substances 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 150000003871 sulfonates Chemical class 0.000 description 2
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 229960001722 verapamil Drugs 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- ISICDUFKKRAFTM-YFKPBYRVSA-N (2S)-3-hydroxy-2-(3-hydroxypropylamino)propanoic acid Chemical compound OCCCN[C@@H](CO)C(=O)O ISICDUFKKRAFTM-YFKPBYRVSA-N 0.000 description 1
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- JDMBMNFESNNWAV-QFIPXVFZSA-N (2s)-2-(icosanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O JDMBMNFESNNWAV-QFIPXVFZSA-N 0.000 description 1
- VNAFZARVZCRBOX-VIFPVBQESA-N (2s)-3-hydroxy-2-(octanoylamino)propanoic acid Chemical compound CCCCCCCC(=O)N[C@@H](CO)C(O)=O VNAFZARVZCRBOX-VIFPVBQESA-N 0.000 description 1
- GMVPRGQOIOIIMI-UHFFFAOYSA-N (8R,11R,12R,13E,15S)-11,15-Dihydroxy-9-oxo-13-prostenoic acid Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CCCCCCC(O)=O GMVPRGQOIOIIMI-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- PXGPLTODNUVGFL-BRIYLRKRSA-N (E,Z)-(1R,2R,3R,5S)-7-(3,5-Dihydroxy-2-((3S)-(3-hydroxy-1-octenyl))cyclopentyl)-5-heptenoic acid Chemical compound CCCCC[C@H](O)C=C[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=CCCCC(O)=O PXGPLTODNUVGFL-BRIYLRKRSA-N 0.000 description 1
- LVRFTAZAXQPQHI-RXMQYKEDSA-N (R)-2-hydroxy-4-methylpentanoic acid Chemical compound CC(C)C[C@@H](O)C(O)=O LVRFTAZAXQPQHI-RXMQYKEDSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 description 1
- RTHCYVBBDHJXIQ-MRXNPFEDSA-N (R)-fluoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-MRXNPFEDSA-N 0.000 description 1
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- NAOLWIGVYRIGTP-UHFFFAOYSA-N 1,3,5-trihydroxyanthracene-9,10-dione Chemical compound C1=CC(O)=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1 NAOLWIGVYRIGTP-UHFFFAOYSA-N 0.000 description 1
- UHKAJLSKXBADFT-UHFFFAOYSA-N 1,3-indandione Chemical class C1=CC=C2C(=O)CC(=O)C2=C1 UHKAJLSKXBADFT-UHFFFAOYSA-N 0.000 description 1
- ZMLPKJYZRQZLDA-UHFFFAOYSA-N 1-(2-phenylethenyl)-4-[4-(2-phenylethenyl)phenyl]benzene Chemical group C=1C=CC=CC=1C=CC(C=C1)=CC=C1C(C=C1)=CC=C1C=CC1=CC=CC=C1 ZMLPKJYZRQZLDA-UHFFFAOYSA-N 0.000 description 1
- OWEGWHBOCFMBLP-UHFFFAOYSA-N 1-(4-chlorophenoxy)-1-(1H-imidazol-1-yl)-3,3-dimethylbutan-2-one Chemical compound C1=CN=CN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 OWEGWHBOCFMBLP-UHFFFAOYSA-N 0.000 description 1
- AFNXATANNDIXLG-SFHVURJKSA-N 1-[(2r)-2-[(4-chlorophenyl)methylsulfanyl]-2-(2,4-dichlorophenyl)ethyl]imidazole Chemical compound C1=CC(Cl)=CC=C1CS[C@H](C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 AFNXATANNDIXLG-SFHVURJKSA-N 0.000 description 1
- MUVQKFGNPGZBII-UHFFFAOYSA-N 1-anthrol Chemical compound C1=CC=C2C=C3C(O)=CC=CC3=CC2=C1 MUVQKFGNPGZBII-UHFFFAOYSA-N 0.000 description 1
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- QXHHHPZILQDDPS-UHFFFAOYSA-N 1-{2-[(2-chloro-3-thienyl)methoxy]-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound S1C=CC(COC(CN2C=NC=C2)C=2C(=CC(Cl)=CC=2)Cl)=C1Cl QXHHHPZILQDDPS-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 1
- VHVPQPYKVGDNFY-DFMJLFEVSA-N 2-[(2r)-butan-2-yl]-4-[4-[4-[4-[[(2r,4s)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one Chemical compound O=C1N([C@H](C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-DFMJLFEVSA-N 0.000 description 1
- KFDNQUWMBLVQNB-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;sodium Chemical group [Na].[Na].[Na].[Na].OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KFDNQUWMBLVQNB-UHFFFAOYSA-N 0.000 description 1
- FCWAUFMDOCOONS-QRPNPIFTSA-N 2-aminoacetic acid;(2s)-2-amino-3-(4-hydroxyphenyl)propanoic acid Chemical compound NCC(O)=O.OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 FCWAUFMDOCOONS-QRPNPIFTSA-N 0.000 description 1
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 description 1
- CMDKPGRTAQVGFQ-UHFFFAOYSA-N 2-ethoxyethyl 3-(4-methoxyphenyl)prop-2-enoate Chemical compound CCOCCOC(=O)C=CC1=CC=C(OC)C=C1 CMDKPGRTAQVGFQ-UHFFFAOYSA-N 0.000 description 1
- AFENDNXGAFYKQO-UHFFFAOYSA-N 2-hydroxybutyric acid Chemical compound CCC(O)C(O)=O AFENDNXGAFYKQO-UHFFFAOYSA-N 0.000 description 1
- BWLBGMIXKSTLSX-UHFFFAOYSA-N 2-hydroxyisobutyric acid Chemical compound CC(C)(O)C(O)=O BWLBGMIXKSTLSX-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- RMTFNDVZYPHUEF-XZBKPIIZSA-N 3-O-methyl-D-glucose Chemical compound O=C[C@H](O)[C@@H](OC)[C@H](O)[C@H](O)CO RMTFNDVZYPHUEF-XZBKPIIZSA-N 0.000 description 1
- IFYVAPPYWOMVDP-ZDUSSCGKSA-N 3-[[(2r)-2,4-diacetyloxy-3,3-dimethylbutanoyl]amino]propyl acetate Chemical compound CC(=O)OCCCNC(=O)[C@H](OC(C)=O)C(C)(C)COC(C)=O IFYVAPPYWOMVDP-ZDUSSCGKSA-N 0.000 description 1
- LAMUXTNQCICZQX-UHFFFAOYSA-N 3-chloropropan-1-ol Chemical compound OCCCCl LAMUXTNQCICZQX-UHFFFAOYSA-N 0.000 description 1
- VOXXWSYKYCBWHO-UHFFFAOYSA-N 3-phenyllactic acid Chemical compound OC(=O)C(O)CC1=CC=CC=C1 VOXXWSYKYCBWHO-UHFFFAOYSA-N 0.000 description 1
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 1
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 1
- QJLXUTBPJPZBAX-UHFFFAOYSA-N 4-amino-2-butylbenzoic acid Chemical compound CCCCC1=CC(N)=CC=C1C(O)=O QJLXUTBPJPZBAX-UHFFFAOYSA-N 0.000 description 1
- ANJLMAHUPYCFQY-UHFFFAOYSA-N 4-phenyl-1h-benzimidazole-2-sulfonic acid Chemical compound C=12NC(S(=O)(=O)O)=NC2=CC=CC=1C1=CC=CC=C1 ANJLMAHUPYCFQY-UHFFFAOYSA-N 0.000 description 1
- 239000002677 5-alpha reductase inhibitor Substances 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 1
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- ITPDYQOUSLNIHG-UHFFFAOYSA-N Amiodarone hydrochloride Chemical compound [Cl-].CCCCC=1OC2=CC=CC=C2C=1C(=O)C1=CC(I)=C(OCC[NH+](CC)CC)C(I)=C1 ITPDYQOUSLNIHG-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- 235000008078 Arctium minus Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000726094 Aristolochia Species 0.000 description 1
- 235000008658 Artemisia capillaris Nutrition 0.000 description 1
- 241000092668 Artemisia capillaris Species 0.000 description 1
- 241000758794 Asarum Species 0.000 description 1
- 240000005343 Azadirachta indica Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 235000021537 Beetroot Nutrition 0.000 description 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 239000004604 Blowing Agent Substances 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000003880 Calendula Nutrition 0.000 description 1
- 240000001432 Calendula officinalis Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 240000006555 Chamaerops humilis Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 241000132536 Cirsium Species 0.000 description 1
- 244000183685 Citrus aurantium Species 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- 240000002319 Citrus sinensis Species 0.000 description 1
- 235000005976 Citrus sinensis Nutrition 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 241000212948 Cnidium Species 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- XECPAIJNBXCOBO-MMPJQOAZSA-N D-glucaro-1,4-lactone Chemical compound OC(=O)[C@@H](O)[C@H]1OC(=O)[C@H](O)[C@H]1O XECPAIJNBXCOBO-MMPJQOAZSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 1
- UYUXSRADSPPKRZ-UHFFFAOYSA-N D-glucuronic acid gamma-lactone Natural products O=CC(O)C1OC(=O)C(O)C1O UYUXSRADSPPKRZ-UHFFFAOYSA-N 0.000 description 1
- UYUXSRADSPPKRZ-SKNVOMKLSA-N D-glucurono-6,3-lactone Chemical compound O=C[C@H](O)[C@H]1OC(=O)[C@@H](O)[C@H]1O UYUXSRADSPPKRZ-SKNVOMKLSA-N 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 206010012444 Dermatitis diaper Diseases 0.000 description 1
- HCYAFALTSJYZDH-UHFFFAOYSA-N Desimpramine Chemical compound C1CC2=CC=CC=C2N(CCCNC)C2=CC=CC=C21 HCYAFALTSJYZDH-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 208000003105 Diaper Rash Diseases 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 102000003951 Erythropoietin Human genes 0.000 description 1
- 108090000394 Erythropoietin Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- XXRCUYVCPSWGCC-UHFFFAOYSA-N Ethyl pyruvate Chemical compound CCOC(=O)C(C)=O XXRCUYVCPSWGCC-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- DSLZVSRJTYRBFB-UHFFFAOYSA-N Galactaric acid Natural products OC(=O)C(O)C(O)C(O)C(O)C(O)=O DSLZVSRJTYRBFB-UHFFFAOYSA-N 0.000 description 1
- 206010017711 Gangrene Diseases 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 108010027814 HSP72 Heat-Shock Proteins Proteins 0.000 description 1
- 102100039165 Heat shock protein beta-1 Human genes 0.000 description 1
- 101710100504 Heat shock protein beta-1 Proteins 0.000 description 1
- 108010004889 Heat-Shock Proteins Proteins 0.000 description 1
- 102000002812 Heat-Shock Proteins Human genes 0.000 description 1
- 241001456088 Hesperocnide Species 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 240000000691 Houttuynia cordata Species 0.000 description 1
- 235000013719 Houttuynia cordata Nutrition 0.000 description 1
- VSNHCAURESNICA-UHFFFAOYSA-N Hydroxyurea Chemical compound NC(=O)NO VSNHCAURESNICA-UHFFFAOYSA-N 0.000 description 1
- 241000546188 Hypericum Species 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 241001656007 Hypoxis hemerocallidea Species 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 239000005906 Imidacloprid Substances 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000006992 Interferon-alpha Human genes 0.000 description 1
- 108010047761 Interferon-alpha Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 102000003777 Interleukin-1 beta Human genes 0.000 description 1
- 108090000193 Interleukin-1 beta Proteins 0.000 description 1
- 102000004125 Interleukin-1alpha Human genes 0.000 description 1
- 108010082786 Interleukin-1alpha Proteins 0.000 description 1
- 102000004889 Interleukin-6 Human genes 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- UETNIIAIRMUTSM-UHFFFAOYSA-N Jacareubin Natural products CC1(C)OC2=CC3Oc4c(O)c(O)ccc4C(=O)C3C(=C2C=C1)O UETNIIAIRMUTSM-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- NGEWQZIDQIYUNV-UHFFFAOYSA-N L-valinic acid Natural products CC(C)C(O)C(O)=O NGEWQZIDQIYUNV-UHFFFAOYSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241000408747 Lepomis gibbosus Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 241000218378 Magnolia Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 235000013500 Melia azadirachta Nutrition 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 206010027627 Miliaria Diseases 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241000282372 Panthera onca Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 244000062780 Petroselinum sativum Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241001674048 Phthiraptera Species 0.000 description 1
- 240000007643 Phytolacca americana Species 0.000 description 1
- 229920001100 Polydextrose Polymers 0.000 description 1
- NKSOSPOXQKNIKJ-CLFAGFIQSA-N Polyoxyethylene dioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCOC(=O)CCCCCCC\C=C/CCCCCCCC NKSOSPOXQKNIKJ-CLFAGFIQSA-N 0.000 description 1
- 229920002675 Polyoxyl Polymers 0.000 description 1
- 229920000153 Povidone-iodine Polymers 0.000 description 1
- SYCBXBCPLUFJID-UHFFFAOYSA-N Pramoxine hydrochloride Chemical compound Cl.C1=CC(OCCCC)=CC=C1OCCCN1CCOCC1 SYCBXBCPLUFJID-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 241000405414 Rehmannia Species 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- 241000543810 Sasa veitchii Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- WNFHGZLVUQBPMA-JSCKKFHOSA-M Sodium glucuronate Chemical compound [Na+].O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C([O-])=O WNFHGZLVUQBPMA-JSCKKFHOSA-M 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241001530209 Swertia Species 0.000 description 1
- 241000779819 Syncarpia glomulifera Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 description 1
- 240000004460 Tanacetum coccineum Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 235000009108 Urtica dioica Nutrition 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 241000254234 Xyeloidea Species 0.000 description 1
- 244000089698 Zanthoxylum simulans Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- OGQICQVSFDPSEI-UHFFFAOYSA-N Zorac Chemical compound N1=CC(C(=O)OCC)=CC=C1C#CC1=CC=C(SCCC2(C)C)C2=C1 OGQICQVSFDPSEI-UHFFFAOYSA-N 0.000 description 1
- VXSIXFKKSNGRRO-MXOVTSAMSA-N [(1s)-2-methyl-4-oxo-3-[(2z)-penta-2,4-dienyl]cyclopent-2-en-1-yl] (1r,3r)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate;[(1s)-2-methyl-4-oxo-3-[(2z)-penta-2,4-dienyl]cyclopent-2-en-1-yl] (1r,3r)-3-[(e)-3-methoxy-2-methyl-3-oxoprop-1-enyl Chemical class CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)O[C@@H]1C(C)=C(C\C=C/C=C)C(=O)C1.CC1(C)[C@H](/C=C(\C)C(=O)OC)[C@H]1C(=O)O[C@@H]1C(C)=C(C\C=C/C=C)C(=O)C1 VXSIXFKKSNGRRO-MXOVTSAMSA-N 0.000 description 1
- ROVGZAWFACYCSP-MQBLHHJJSA-N [2-methyl-4-oxo-3-[(2z)-penta-2,4-dienyl]cyclopent-2-en-1-yl] (1r,3r)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OC1C(C)=C(C\C=C/C=C)C(=O)C1 ROVGZAWFACYCSP-MQBLHHJJSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- BZKPWHYZMXOIDC-UHFFFAOYSA-N acetazolamide Chemical compound CC(=O)NC1=NN=C(S(N)(=O)=O)S1 BZKPWHYZMXOIDC-UHFFFAOYSA-N 0.000 description 1
- 229960000571 acetazolamide Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229920006322 acrylamide copolymer Polymers 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 229960002916 adapalene Drugs 0.000 description 1
- LZCDAPDGXCYOEH-UHFFFAOYSA-N adapalene Chemical compound C1=C(C(O)=O)C=CC2=CC(C3=CC=C(C(=C3)C34CC5CC(CC(C5)C3)C4)OC)=CC=C21 LZCDAPDGXCYOEH-UHFFFAOYSA-N 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- HXHWSAZORRCQMX-UHFFFAOYSA-N albendazole Chemical compound CCCSC1=CC=C2NC(NC(=O)OC)=NC2=C1 HXHWSAZORRCQMX-UHFFFAOYSA-N 0.000 description 1
- 229960002669 albendazole Drugs 0.000 description 1
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 239000003619 algicide Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 150000001345 alkine derivatives Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 description 1
- 229960003459 allopurinol Drugs 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- LVRFTAZAXQPQHI-UHFFFAOYSA-N alpha-hydroxyisocaproic acid Natural products CC(C)CC(O)C(O)=O LVRFTAZAXQPQHI-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229960000711 alprostadil Drugs 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- JTDNJBUOVNNSOG-UHFFFAOYSA-N amino ethanesulfonate Chemical class CCS(=O)(=O)ON JTDNJBUOVNNSOG-UHFFFAOYSA-N 0.000 description 1
- 229960005260 amiodarone Drugs 0.000 description 1
- 229940025084 amphetamine Drugs 0.000 description 1
- 201000002996 androgenic alopecia Diseases 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000002682 anti-psoriatic effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 229940125683 antiemetic agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000003524 antilipemic agent Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000003200 antithyroid agent Substances 0.000 description 1
- 229940043671 antithyroid preparations Drugs 0.000 description 1
- 239000003434 antitussive agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- BBFQZRXNYIEMAW-UHFFFAOYSA-N aristolochic acid I Chemical compound C1=C([N+]([O-])=O)C2=C(C(O)=O)C=C3OCOC3=C2C2=C1C(OC)=CC=C2 BBFQZRXNYIEMAW-UHFFFAOYSA-N 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 229960005193 avobenzone Drugs 0.000 description 1
- 229960002255 azelaic acid Drugs 0.000 description 1
- 229940116224 behenate Drugs 0.000 description 1
- UKMSUNONTOPOIO-UHFFFAOYSA-M behenate Chemical compound CCCCCCCCCCCCCCCCCCCCCC([O-])=O UKMSUNONTOPOIO-UHFFFAOYSA-M 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960005274 benzocaine Drugs 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- YEAYGXLRPMKZBP-KQGICBIGSA-N bis(2-hydroxyethyl)azanium;(e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound OCCNCCO.COC1=CC=C(\C=C\C(O)=O)C=C1 YEAYGXLRPMKZBP-KQGICBIGSA-N 0.000 description 1
- JAONZGLTYYUPCT-UHFFFAOYSA-K bismuth subgallate Chemical compound OC(=O)C1=CC(O)=C2O[Bi](O)OC2=C1 JAONZGLTYYUPCT-UHFFFAOYSA-K 0.000 description 1
- 229960000199 bismuth subgallate Drugs 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229920005605 branched copolymer Polymers 0.000 description 1
- OZVBMTJYIDMWIL-AYFBDAFISA-N bromocriptine Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N[C@]2(C(=O)N3[C@H](C(N4CCC[C@H]4[C@]3(O)O2)=O)CC(C)C)C(C)C)C2)=C3C2=C(Br)NC3=C1 OZVBMTJYIDMWIL-AYFBDAFISA-N 0.000 description 1
- 229960002802 bromocriptine Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- CNYFJCCVJNARLE-UHFFFAOYSA-L calcium;2-sulfanylacetic acid;2-sulfidoacetate Chemical compound [Ca+2].[O-]C(=O)CS.[O-]C(=O)CS CNYFJCCVJNARLE-UHFFFAOYSA-L 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 239000001722 capsicum frutescens oleoresin Substances 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 229940050948 capsicum oleoresin Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical group 0.000 description 1
- 238000009960 carding Methods 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 229920003118 cationic copolymer Polymers 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 239000012461 cellulose resin Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- UHZZMRAGKVHANO-UHFFFAOYSA-M chlormequat chloride Chemical compound [Cl-].C[N+](C)(C)CCCl UHZZMRAGKVHANO-UHFFFAOYSA-M 0.000 description 1
- 235000019365 chlortetracycline Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 229960003749 ciclopirox Drugs 0.000 description 1
- SCKYRAXSEDYPSA-UHFFFAOYSA-N ciclopirox Chemical compound ON1C(=O)C=C(C)C=C1C1CCCCC1 SCKYRAXSEDYPSA-UHFFFAOYSA-N 0.000 description 1
- AQIXAKUUQRKLND-UHFFFAOYSA-N cimetidine Chemical compound N#C/N=C(/NC)NCCSCC=1N=CNC=1C AQIXAKUUQRKLND-UHFFFAOYSA-N 0.000 description 1
- 229960001380 cimetidine Drugs 0.000 description 1
- PUFQVTATUTYEAL-UHFFFAOYSA-N cinchocaine Chemical compound C1=CC=CC2=NC(OCCCC)=CC(C(=O)NCCN(CC)CC)=C21 PUFQVTATUTYEAL-UHFFFAOYSA-N 0.000 description 1
- 229960001747 cinchocaine Drugs 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- 235000013477 citrulline Nutrition 0.000 description 1
- 229960003344 climbazole Drugs 0.000 description 1
- 229960004022 clotrimazole Drugs 0.000 description 1
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 239000011280 coal tar Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 239000000039 congener Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 description 1
- 239000004062 cytokinin Substances 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 1
- 229960000975 daunorubicin Drugs 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000035614 depigmentation Effects 0.000 description 1
- 230000002951 depilatory effect Effects 0.000 description 1
- 229960003914 desipramine Drugs 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 229960001673 diethyltoluamide Drugs 0.000 description 1
- 229940120503 dihydroxyacetone Drugs 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- UKHVLWKBNNSRRR-ODZAUARKSA-M dowicil 200 Chemical compound [Cl-].C1N(C2)CN3CN2C[N+]1(C\C=C/Cl)C3 UKHVLWKBNNSRRR-ODZAUARKSA-M 0.000 description 1
- 229960004679 doxorubicin Drugs 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 229940105423 erythropoietin Drugs 0.000 description 1
- 229960000285 ethambutol Drugs 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- AEOCXXJPGCBFJA-UHFFFAOYSA-N ethionamide Chemical compound CCC1=CC(C(N)=S)=CC=N1 AEOCXXJPGCBFJA-UHFFFAOYSA-N 0.000 description 1
- 229940117360 ethyl pyruvate Drugs 0.000 description 1
- BCZNQGCLALQXBN-UHFFFAOYSA-M ethylbenzene;chloride Chemical compound [Cl-].C[CH+]C1=CC=CC=C1 BCZNQGCLALQXBN-UHFFFAOYSA-M 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 150000002194 fatty esters Chemical class 0.000 description 1
- 102000034240 fibrous proteins Human genes 0.000 description 1
- 108091005899 fibrous proteins Proteins 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 150000002211 flavins Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 229960002464 fluoxetine Drugs 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- DSLZVSRJTYRBFB-DUHBMQHGSA-N galactaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O DSLZVSRJTYRBFB-DUHBMQHGSA-N 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- 235000012209 glucono delta-lactone Nutrition 0.000 description 1
- 229960003681 gluconolactone Drugs 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 229950002441 glucurolactone Drugs 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000005908 glyceryl ester group Chemical group 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229960004275 glycolic acid Drugs 0.000 description 1
- 239000003966 growth inhibitor Substances 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 239000003051 hair bleaching agent Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- CKAPSXZOOQJIBF-UHFFFAOYSA-N hexachlorobenzene Chemical compound ClC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl CKAPSXZOOQJIBF-UHFFFAOYSA-N 0.000 description 1
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000014304 histidine Nutrition 0.000 description 1
- 239000003061 homeopathic agent Substances 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 210000004276 hyalin Anatomy 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- SKHIBNDAFWIOPB-UHFFFAOYSA-N hydron;2-phenylethanamine;chloride Chemical compound Cl.NCCC1=CC=CC=C1 SKHIBNDAFWIOPB-UHFFFAOYSA-N 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 229920013821 hydroxy alkyl cellulose Polymers 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229960001330 hydroxycarbamide Drugs 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 229940056881 imidacloprid Drugs 0.000 description 1
- YWTYJOPNNQFBPC-UHFFFAOYSA-N imidacloprid Chemical compound [O-][N+](=O)\N=C1/NCCN1CC1=CC=C(Cl)N=C1 YWTYJOPNNQFBPC-UHFFFAOYSA-N 0.000 description 1
- BCGWQEUPMDMJNV-UHFFFAOYSA-N imipramine Chemical compound C1CC2=CC=CC=C2N(CCCN(C)C)C2=CC=CC=C21 BCGWQEUPMDMJNV-UHFFFAOYSA-N 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910003480 inorganic solid Inorganic materials 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940060384 isostearyl isostearate Drugs 0.000 description 1
- 229960004130 itraconazole Drugs 0.000 description 1
- VHVPQPYKVGDNFY-ZPGVKDDISA-N itraconazole Chemical compound O=C1N(C(C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-ZPGVKDDISA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000008633 juniper tar Substances 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- BTNMPGBKDVTSJY-UHFFFAOYSA-N keto-phenylpyruvic acid Chemical compound OC(=O)C(=O)CC1=CC=CC=C1 BTNMPGBKDVTSJY-UHFFFAOYSA-N 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 229940071188 lauroamphodiacetate Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 description 1
- 229910052808 lithium carbonate Inorganic materials 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- ZHALCRSGRSWRHV-UHFFFAOYSA-L magnesium;2-sulfanylacetate Chemical compound [Mg+2].[O-]C(=O)CS.[O-]C(=O)CS ZHALCRSGRSWRHV-UHFFFAOYSA-L 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- GUMSHIGGVOJLBP-SLRPQMTOSA-N methyl hesperidin Chemical compound C1=C(OC)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 GUMSHIGGVOJLBP-SLRPQMTOSA-N 0.000 description 1
- CWKLZLBVOJRSOM-UHFFFAOYSA-N methyl pyruvate Chemical compound COC(=O)C(C)=O CWKLZLBVOJRSOM-UHFFFAOYSA-N 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 201000004169 miliaria rubra Diseases 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 229960005406 motretinide Drugs 0.000 description 1
- IYIYMCASGKQOCZ-DJRRULDNSA-N motretinide Chemical compound CCNC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C=C(OC)C(C)=C1C IYIYMCASGKQOCZ-DJRRULDNSA-N 0.000 description 1
- KUYQDJOFVBGZID-UHFFFAOYSA-N n,n-diethyl-2-methylbenzamide Chemical compound CCN(CC)C(=O)C1=CC=CC=C1C KUYQDJOFVBGZID-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 1
- 229930019673 naringin Natural products 0.000 description 1
- 229940052490 naringin Drugs 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- NGBBFNQEPSYETA-UHFFFAOYSA-N octadecanoic acid;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCCCCCC(O)=O NGBBFNQEPSYETA-UHFFFAOYSA-N 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- 229960000601 octocrylene Drugs 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- HUGZTWBSBIZZOQ-UHFFFAOYSA-N octyl 2-methyl-3-phenylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C(C)=CC1=CC=CC=C1 HUGZTWBSBIZZOQ-UHFFFAOYSA-N 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- LXTZRIBXKVRLOA-UHFFFAOYSA-N padimate a Chemical compound CCCCCOC(=O)C1=CC=C(N(C)C)C=C1 LXTZRIBXKVRLOA-UHFFFAOYSA-N 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 229940023735 panthenyl ethyl ether Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 239000000734 parasympathomimetic agent Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 description 1
- 235000011197 perejil Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229960000490 permethrin Drugs 0.000 description 1
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- CGIHFIDULQUVJG-VNTMZGSJSA-N phytantriol Natural products CC(C)CCC[C@H](C)CCC[C@H](C)CCC[C@@](C)(O)[C@H](O)CO CGIHFIDULQUVJG-VNTMZGSJSA-N 0.000 description 1
- CGIHFIDULQUVJG-UHFFFAOYSA-N phytantriol Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)(O)C(O)CO CGIHFIDULQUVJG-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000001739 pinus spp. Substances 0.000 description 1
- 229960005235 piperonyl butoxide Drugs 0.000 description 1
- 229950001046 piroctone Drugs 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000001259 polydextrose Substances 0.000 description 1
- 235000013856 polydextrose Nutrition 0.000 description 1
- 229940035035 polydextrose Drugs 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 description 1
- 229940116357 potassium thiocyanate Drugs 0.000 description 1
- OEEUOVDUVFUJCL-KQGICBIGSA-M potassium;(e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound [K+].COC1=CC=C(\C=C\C([O-])=O)C=C1 OEEUOVDUVFUJCL-KQGICBIGSA-M 0.000 description 1
- HYTYHTSMCRDHIM-UHFFFAOYSA-M potassium;2-sulfanylacetate Chemical compound [K+].[O-]C(=O)CS HYTYHTSMCRDHIM-UHFFFAOYSA-M 0.000 description 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
- 229960001621 povidone-iodine Drugs 0.000 description 1
- 229940019974 pramoxine hydrochloride Drugs 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- WUBJISGMPZWFKY-UHFFFAOYSA-N propan-2-yl 2-oxopropanoate Chemical compound CC(C)OC(=O)C(C)=O WUBJISGMPZWFKY-UHFFFAOYSA-N 0.000 description 1
- 229960003712 propranolol Drugs 0.000 description 1
- GMVPRGQOIOIIMI-DWKJAMRDSA-N prostaglandin E1 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O GMVPRGQOIOIIMI-DWKJAMRDSA-N 0.000 description 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 1
- PXGPLTODNUVGFL-UHFFFAOYSA-N prostaglandin F2alpha Natural products CCCCCC(O)C=CC1C(O)CC(O)C1CC=CCCCC(O)=O PXGPLTODNUVGFL-UHFFFAOYSA-N 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 102000034272 protein filaments Human genes 0.000 description 1
- 108091005974 protein filaments Proteins 0.000 description 1
- 229940121649 protein inhibitor Drugs 0.000 description 1
- 239000012268 protein inhibitor Substances 0.000 description 1
- 235000020236 pumpkin seed Nutrition 0.000 description 1
- HYJYGLGUBUDSLJ-UHFFFAOYSA-N pyrethrin Natural products CCC(=O)OC1CC(=C)C2CC3OC3(C)C2C2OC(=O)C(=C)C12 HYJYGLGUBUDSLJ-UHFFFAOYSA-N 0.000 description 1
- 229940070846 pyrethrins Drugs 0.000 description 1
- 239000002728 pyrethroid Substances 0.000 description 1
- 229940015367 pyrethrum Drugs 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 229940047670 sodium acrylate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940104870 sodium magnesium fluorosilicate Drugs 0.000 description 1
- SDKPSXWGRWWLKR-UHFFFAOYSA-M sodium;9,10-dioxoanthracene-1-sulfonate Chemical compound [Na+].O=C1C2=CC=CC=C2C(=O)C2=C1C=CC=C2S(=O)(=O)[O-] SDKPSXWGRWWLKR-UHFFFAOYSA-M 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- LXMSZDCAJNLERA-ZHYRCANASA-N spironolactone Chemical compound C([C@@H]1[C@]2(C)CC[C@@H]3[C@@]4(C)CCC(=O)C=C4C[C@H]([C@@H]13)SC(=O)C)C[C@@]21CCC(=O)O1 LXMSZDCAJNLERA-ZHYRCANASA-N 0.000 description 1
- 229960002256 spironolactone Drugs 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- JEUDXCQTVURKDL-UHFFFAOYSA-L strontium;2-sulfanylacetate Chemical compound [Sr+2].[O-]C(=O)CS.[O-]C(=O)CS JEUDXCQTVURKDL-UHFFFAOYSA-L 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 229960002607 sulconazole Drugs 0.000 description 1
- NCEXYHBECQHGNR-QZQOTICOSA-N sulfasalazine Chemical compound C1=C(O)C(C(=O)O)=CC(\N=N\C=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-QZQOTICOSA-N 0.000 description 1
- 229960001940 sulfasalazine Drugs 0.000 description 1
- NCEXYHBECQHGNR-UHFFFAOYSA-N sulfasalazine Natural products C1=C(O)C(C(=O)O)=CC(N=NC=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-UHFFFAOYSA-N 0.000 description 1
- 229940037128 systemic glucocorticoids Drugs 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229960000565 tazarotene Drugs 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- 229910052716 thallium Inorganic materials 0.000 description 1
- BKVIYDNLLOSFOA-UHFFFAOYSA-N thallium Chemical compound [Tl] BKVIYDNLLOSFOA-UHFFFAOYSA-N 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- ZEMGGZBWXRYJHK-UHFFFAOYSA-N thiouracil Chemical compound O=C1C=CNC(=S)N1 ZEMGGZBWXRYJHK-UHFFFAOYSA-N 0.000 description 1
- 229950000329 thiouracil Drugs 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 229960004214 tioconazole Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 229940036248 turpentine Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- AZJYLVAUMGUUBL-UHFFFAOYSA-A u1qj22mc8e Chemical compound [F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O=[Si]=O.O=[Si]=O.O=[Si]=O.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 AZJYLVAUMGUUBL-UHFFFAOYSA-A 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 1
- 229960004528 vincristine Drugs 0.000 description 1
- OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- HBOMLICNUCNMMY-XLPZGREQSA-N zidovudine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 HBOMLICNUCNMMY-XLPZGREQSA-N 0.000 description 1
- 229960002555 zidovudine Drugs 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229940043810 zinc pyrithione Drugs 0.000 description 1
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
- C11D17/04—Detergent materials or soaps characterised by their shape or physical properties combined with or containing other objects
- C11D17/049—Cleaning or scouring pads; Wipes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A61K8/416—Quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/604—Alkylpolyglycosides; Derivatives thereof, e.g. esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/88—Ampholytes; Electroneutral compounds
- C11D1/94—Mixtures with anionic, cationic or non-ionic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/596—Mixtures of surface active compounds
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/66—Non-ionic compounds
- C11D1/662—Carbohydrates or derivatives
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/88—Ampholytes; Electroneutral compounds
- C11D1/90—Betaines
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Detergent Compositions (AREA)
Abstract
本发明公开了一种温和的清洗组合物,其能产生稳定的泡沫,含有至少一种糖苷类非离子表面活性剂;至少一种甜菜碱表面活性剂;和至少一种两性表面活性剂。这种组合物基本上不含有阴离子表面活性剂。
Description
相关申请
本申请是在美国2001年8月16日申请的09/931,703号申请的部分续展申请,在此将其全部引入作为参考。
发明背景
发明领域
本发明涉及一种能产生稳定的泡沫,同时对眼睛和皮肤只有低度刺激的皮肤和头发清洁组合物。更具体的是,本发明涉及的这类组合物是含有甜菜碱表面活性剂,两性表面活性剂和非离子表面活性剂的混合物。该组合物基本上不含阴离子表面活性剂。
现有技术的描述
众所周知,在洗发和清洗组合物中所使用的许多表面活性剂对眼睛是有刺激作用的,尤其是那些用于婴幼儿和儿童的洗发和清洗组合物更受到人们的关注。因此,人们已经开发出几种几乎没有刺激作用的表面活性剂。
泡沫是评价清洗组合物性能的重要指标,尤其是人们亲身使用的产品,例如:洗发精,身体清洗剂,洗手剂,脸清洗剂等。泡沫的质量和数量可以给消费者一个重要的暗示:此种产品是高效,优质的产品。泡沫还可以起到功能性作用,它能帮助皮肤和头发上的污垢乳化而且能把乳化后的污垢带走。
表面活性剂,尤其阴离子表面活性剂是当今用于清洗组合物中形成泡沫的主要成分。阴离子表面活性剂,例如硫酸盐,磺酸盐,羟乙磺酸盐,磺基琥珀酸盐和牛磺酸盐,已知能够提供大量非常稳定的泡沫。然而,阴离子表面活性剂不是没有缺点。例如,阴离子表面活性剂可能会剥离皮肤和头发上的天然油脂,从而会损害头发,并且使皮肤干燥而受到伤害。阴离子表面活性剂还被认为对皮肤和眼睛有刺激作用。为此,含有阴离子表面活性剂的清洗组合物可能不适合婴儿及那些皮肤有损伤或者有过敏性皮肤的人们使用。
另外,阴离子表面活性剂常常易于水解,因此其不适宜在低pH值环境中使用。此外,阴离子表面活性剂可能与阳离子成分不相容,因此其不适宜在一些应用中使用。
用于减小阴离子表面活性剂有害作用的另一种表面活性剂包括两性和非离子表面活性剂。然而,尽管这些表面活性剂不具有上述阴离子表面活性剂所具有的不足之处,但是相对于阴离子表面活性剂来讲,他们的缺点是其所产生的泡沫少,且不稳定。这是其为什么不能广泛地用作主要发泡剂剂的一个原因。但是参考专利合作条约(PCT)专利申请号WO 97/47171,由烷基聚糖苷(glucoside)非离子表面活性剂和两性表面活性剂组成的发泡体系。虽然这种两性一非离子体系能够产生泡沫,但是泡沫不稳定,也就是不持久。
因此,需要一种能产生大量稳定、密集泡沫的,基于两性和非离子表面活性剂的清洗组合物,但同时它又不具有已知的阴离子表面活性剂的那些有害的作用。
发明概述
本发明提供一种温和的、能够产生稳定的泡沫的清洗组合物,它基本上由和/或由下列物质构成:至少一种糖苷类非离子表面活性剂;至少一种甜菜碱(betaine)表面活性剂;至少一种两性表面活性剂,其中组合物基本上没有阴离子表面活性剂。
出乎我们的意料,我们发现本发明的清洗组合物不仅能有效地提供优质稳定的泡沫,而且同时对皮肤和眼睛的刺激很小。
优选技术方案的详细描述
本发明清洗剂的第一种成份至少是一种糖苷类非离子表面活性剂。糖苷是非离子表面活性剂,其具有包含大约6至30个碳原子的憎水基团和含有大约1到10个糖类单元的多聚糖(多聚糖苷)亲水基团。适当的糖苷包括,但是并不仅限于,椰子糖苷,辛基糖苷,癸基糖苷,月桂基糖苷以及它们的混合物。本发明清洗组合物中糖苷重量占清洗组合物总重量的比例范围从约0.1%到约20%,例如,从约0.5%到约15%或从约1.0%到约10%。
本发明清洗组合物的第二种成份是至少一种甜菜碱表面活性剂。此处所使用的甜菜碱在低pH值,即4或更小时,是阳离子,在中等pH值,例如大约7时是等电的。适宜的甜菜碱表面活性剂包括,但是并不仅限于,烷基甜菜碱,例如癸基甜菜碱,诸如十二烷基羟基磺基甜菜碱的烷基磺基甜菜碱,诸如古柯酰氨基丙基甜菜碱的酰氨基烷基甜菜碱,诸如油酰氨基丙基羟基磺基甜菜碱的酰氨基烷基磺基甜菜碱,以及它们的混合物,此处的烷基含有大约8到大约22个碳原子。按重量计算,本发明的清洗组合物中甜菜碱表面活性剂重量占组合物总重量的范围从约0.1%到约20%,例如,从约0.5%到约15%,或从约1.0%到约10%。
本发明的清洗组合物中第三个成份至少是一种两性表面活性剂,依据pH值的不同,其可能以三种不同形式存在:在低的pH值即4或更小时,为阳离子,在中间的pH值即在约7时,为两性离子,在高的pH值即约10或更高时为阴离子。适宜的两性表面活性剂包括,但并不仅限于,两性羧酸盐,烷基酰氨基烷基胺,烷基取代氨基酸,两性磷酸盐,聚羧烷基烷基胺,以及它们的混合物,其中烷基含有大约8到大约22个碳原子。特别适宜的两性表面活性剂包括,但并不仅限于,月桂两性二乙酸盐,月桂亚氨基二丙酸盐,椰子两性丙酸盐,月桂两性二丙酸,辛基两性羟基丙基磺酸盐,以及它们的混合物。本发明组合物中两性表面活性剂的重量占清洗组合物总重量的范围,从大约0.1%到大约20%,例如从大约0.5%到大约15%,或从大约1.0%到大约10%。
此处所提出的两性表面活性剂并没有涉及其抗衡离子。本领域普通技术人员很容易理解在本项发明的组合物的pH值条件下,两性表面活性剂或者由于其具有相平衡的正负电荷而呈电中性,要不就是它们具有相抗衡的离子,例如,但不仅限于,碱金属,碱土金属,或铵抗衡离子。
糖苷类非离子表面活性剂与两性表面活性剂和甜菜碱表面活性剂总量的比例范围可能从大约1∶4到大约1.5∶1。甜菜碱表面活性剂与两性表面活性剂的比例范围可能从大约1∶2到大约10∶1。糖苷类非离子表面活性剂与甜菜碱表面活性剂及两性表面活性剂的比例范围分别从大约1∶1.3∶2.66到大约16.5∶10∶1。
本发明的组合物基本上没有阴离子表面活性剂。此处所说的“基本上没有阴离子表面活性剂”意味着组合物中含有的阴离子表面活性剂的重量占组合物总重量的比例小于1%,例如小于约0.5%或约0.1%。此处所说的术语“阴离子表面活性剂”是表示带有负电荷的表面活性剂,它们包括,但并不仅限于,硫酸盐,磺酸盐,羟乙磺酸盐,硫代琥珀酸盐,氨基乙磺酸盐,以及它们的混合物。
本发明的组合物中添加其重量占组合物总量的比例从大约0.5%到大约5%的其他表面活性剂可能会有益处。用于本发明中的一类非离子表面活性剂是多羟基酯的聚氧乙烯衍生物,此处的多羟基酯的聚氧乙烯衍生物(1)衍生自(a)含有从大约8到大约22个碳原子,优选是从大约10到大约14个碳原子的脂肪酸,而且(b)多羟基化合物选自山梨醇,山梨聚糖,葡萄糖,α-甲基糖苷,每个分子中含有平均1到3个葡萄糖残基的多聚葡萄糖,丙三醇,季戊四醇以及它们的混合物,(2)含有平均从大约10到大约120,优选从大约20到大约80个氧乙烯基团;以及(3)每个多羟基酯的聚氧乙烯衍生物的分子中平均含有大约1到3个脂肪酸残基。
优选的多羟基酯的聚氧乙烯衍生物的例子包括,但不仅限于,聚乙二醇-80(PEG-80)山梨聚糖月桂酸酯和聚山梨醇酯20(polysorbate 20)。美国特拉华州Wilmington的ICI Surfactants公司有聚乙二醇-80山梨聚糖月桂酸酯商品出售,其商品名称为“Atlas G-4280”,是具有平均大约80摩尔环氧乙烷分子乙氧基化的月桂酸山梨聚糖单酯。美国特拉华州Wilmington的ICI Surfactants公司有聚山梨醇酯20(polysorbate 20)出售,其商品名称为“Tween 20”,它是具有山梨糖醇和具有大约20个环氧乙烷缩聚的山梨(糖)醇酐混合物的月桂酸单酯。
另外,本发明的清洗组合物还包含至少一种主要的调节剂,其重量占清洗组合物总重量的比例,从大约0.01%到大约1.0%,例如从大约0.01%到大约0.5%或从大约0.01%到大约0.2%。
适宜的主要调节剂包括,但不仅限于,这样一些阳离子调节聚合物,其分子量范围从大约2,000到大约5,000,000,例如从大约5,000到大约3,000,000或从大约100,000到大约1,000,000。
具有代表性的一类适宜的阳离子调节聚合物包括,但不仅限于,阳离子多聚糖;阳离子均聚物和衍生自丙烯酸和/或甲基丙烯酸的共聚物;阳离子纤维素树脂;氯化二甲基二丙烯基铵,丙烯酰胺和/或丙烯酸的阳离子共聚物;氯化二甲基二丙烯基铵阳离子均聚物;阳离子聚烯烃和乙氧基聚烯烃亚胺;季铵化硅橡胶以及它们的共聚物和混合物。例如,这样的阳离子聚合物包括阳离子瓜耳树脂,例如氯化瓜耳羟基丙基三鎓(monium),其可从Rhodia Incorporated以商品名称“Jaguar C17”购得;季铵化羟基乙基纤维素醚,例如,多季铵盐10,其Amerchol Corporation以商品名称为“Ucare Polymer JR 400”购得;丙烯酰胺和氯化二甲基二丙烯基铵醚的共聚物,其又是已知的多季铵盐7,其可从Mcintyre Group Ltd.以商品名称“Mackemium 007”购得,从Allied Colloids也可购得此商品,其名称为“Salcare SC10”;乙烯吡咯烷酮和季铵化的带支链的乙烯吡咯烷酮的共聚物,其可从BASF Corporation购得,商品名称为“Luviquat Care”;从Allied Colloids可购得的多季铵盐-6,其商品名称为“Salcare SC30”;以及它们的共聚物和混合物。
在一个实施方案中,主要的调节剂,以清洗组合物总重量为基准,含有或基本上含有从大约0.01%到大约0.5%,例如从大约0.01%到大约0.2%,阳离子瓜耳衍生物,和从大约0.01%到大约0.5%,例如从大约0.01%到大约0.2%的氯化二甲基二丙烯基铵的均聚物或共聚物。
在另一个实施方案中,主要的调节剂,以清洗组合物总重量为基准,含有和/或基本上含有从大约0.01%到大约5%,例如从大约0.01%到大约3%或者从大约0.01%到2%的阳离子调节聚合物;从大约0.1%到大约5%,例如从大约0.5%到大约3%或者从大约0.1%到大约2.5%的从含有二酯,三酯,或它们的混合物中筛选出的润肤剂;以及从大约0.1%到大约10%,例如从大约0.5%到大约5%或从大约0.75%到大约3%的单酯润肤剂。
适宜的二酯或三酯润肤剂可以通过已知的反应由脂肪烷氧基化酯与直链、支链或芳香多羟基化合物或多元酸反应而形成直链、支链或芳香多羟基化合物或多元酸的二酯或三酯制得。二酯或三酯的反应物分别包含二个或三个脂肪烷氧基化部分,其结构如分子式I所示:
其中:
R1是具有有碳链长度为大约6到30个原子的饱和或不有饱和的,取代或未取代的,直链,支链,或芳香脂肪族部分;而且
每个x和y分别为0或从1到200的整数,同时要符合下述条件:每个脂肪族烷氧基部分中x和y的总和各自在1到300之间,并且在二酯或三酯中所有x和y的总数不超过800。
其中:
M1,M2,和M3分别是羟基,二个单键的氢原子,或者是一个双键的氧原子;
Zp,Zq和Zr分别是氢原子或羟基;
p,q和r分别是0或1,但p+q+r的总数是至少是2;并且
w是0或者是一个1到20之间的整数。
一个适宜的二酯是双-PPG-2-Myreth-10Adipate(己二酸酯),其由Croda,Incorporated购得,商品名称为“Cromollient SCE”,其结构如分子式III所示:
本发明中所使用适宜的单酯润肤剂包括通过已知的由含有从大约4到30个碳原子的直链、支链或芳香脂肪酸与直链、支链、或芳香一元或多元醇反应所制得的酯。如果需要的话,可以应用已知的方法对一元或多元醇进行烷氧基化反应以改进其水溶性。生成的单酯的结构由分子式IV表示:
其中:
R2是饱和或不饱和、取代或非取代、直链、支链或芳香脂肪族部分,其碳链长度为从大约4至30个原子;
R3是饱和或不饱和、取代或非取代、直链、支链或一元或多元芳香醇,其碳链长度为大约从3至30个原子;而且
每个e,f,s和t分别是0或者是1到100的整数,前提条件是e和f的总数是0或者是1至200之间的整数,s和t的总数是0或者是1至200之间的整数,而且e,f,s和t的总数不超过400。
本发明中所使用的适宜的单酯的例子包括丙三基的酯,例如丙三基油酸酯,其由Goldschmidt Chemical Corporation购得,商品名称为“Tegin O”;聚乙二醇-7(PEG-7)丙三基椰子酯,其由Croda Icorporated购得,商品名称为“GlyceroxHE”;以及它们的混合物。
在一个实施方案中,双/三酯润肤剂和单酯润肤剂的一个或多个HLB值大约小于11,例如从大约2到11或从大约4到约11。在另外的一个实施方案中,所有的双/三酯润肤剂和单酯润肤剂的HLB均小于11,例如从大约2到大约11或从大约4到大约11。
本发明的清洗组合物可能包含螯合剂。适当的螯合剂的例子包括能够保护本发明的组合物的物质。较优选的螯合剂是乙二胺四乙酸,更加优选的螯合剂是乙二胺四乙酸四钠,其由Dow Chemical Company of Midland,Michigan购得,商品名称为“Versene 100XL”,而且以组合物总重量为标准,其用量从大约0到0.5%,例如从大约0.05%到0.25%。
本发明的组合物可以选择性地包括防腐剂。适宜的防腐剂包括,但并不仅限于,Quatemium-15,其由Dow Chemical Company of Midland,Michigan以商品名“Dowicil 200”购得,以及氯化杀藻胺,以组合物总重量为基准,其在组合物中的重量,从大约0到0.2%,例如从大约0.05%到0.10%。
可选择性的,本发明的组合物中可以含有助剂。所谓助剂就是任何活性成分,其将被用于皮肤的某些部位,例如化妆品助剂或药物助剂。所谓“化妆品助剂”就是能够提供化妆处理的任何成分,其通过局部施用对头发和/或皮肤提供营养和/或进行调节。所谓“药物助剂”就是指在性质上是憎水或亲水能供局部使用的任何药物。此处所使用的“药物助剂”包括那些能够促进损伤和疾病恢复的试剂。
适宜助剂的例子包括,但并不仅限于,脱色剂;反射剂;增稠剂;梳理/湿气梳毛剂;形成薄膜聚合物;保湿剂;氨基酸助剂;杀菌剂;过敏症抑制剂;抗痤疮助剂;抗老化助剂;抗皱纹助剂;防腐剂;止痛剂;止咳药;止痒剂;局部麻醉剂;防脱发剂;头发生长促进剂;头发生长抑制剂;抗组织胺剂;抗传染剂;炎症抑制剂;防呕吐剂;抗副交感神经生理作用试剂;血管收缩神经试剂;血管扩张神经试剂;伤害痊愈促进剂;缩氨酸,多肽和蛋白质;除臭剂和防出汗剂;医药试剂;皮肤软化剂和皮肤润湿剂;维生素;使皮肤晒成褐色试剂;皮肤增亮剂;例如在脚上使用的抗真菌试剂;脱毛剂;剔须制剂;外用止痛剂;香水;反刺激剂;防痔疮试剂;杀虫剂;有毒的常春藤制品;有毒药的橡树制品;灼伤制品;抗尿疹制剂;痱子制剂;化妆制品;维生素;氨基酸及其衍生物;中草药萃取物;类维生素A;黄素遗子;知觉剂;抗氧化剂;中级的头发及皮肤调节剂;珍珠制剂;头发增亮剂;螯合剂;细胞修复增强剂;颜色;颜料;遮光剂及其类似物,以及它们的混合物。
市场上出售的珍珠制剂或遮光剂由于能够使如硅橡胶类的不溶于水的添加剂悬浮在水中,和/或者其能够向消费者表明它的最终产品是已经调节好的洗发香波而适用于本发明的组合物。以组合物总重量为基准,珍珠制剂或遮光剂的用量从大约1%到10%,优选从大约1.5%到7%,更优选从大约2%到5%。适宜的珍珠制剂或遮光剂包括,但并不仅限于,由(a)具有从大约16到22个碳原子的脂肪酸和(b)乙二醇或丙二醇所组成的单酯或二酯;由(a)具有从大约16到22个碳原子的脂肪酸和(b)聚亚烷基乙二醇所生成的单酯或二酯,聚亚烷基乙二醇的分子式为:HO-(JO)a-H,其中J是一个具有从大约2到3个碳原子的亚烷基;a是2或3;含有从大约16到22个碳原子的脂肪醇;具有分子式为KCOOCH2L的脂肪酯,其中K和L分别含有大约15到21个碳原子;不能溶解在洗发精中的无机固体,以及它们的混合物。
适宜的反射剂的例子不只包括云母,矾土,硅酸钙,乙二醇二油酸酯,乙二醇二硬脂酸酯,硅土,氟硅酸钠镁,以及它们的混合物。
适宜的紫外线吸收剂的例子包括苯甲酮,波尼酮,丁基对氨基苯甲酸,氯化肉桂氨基丙基三甲基铵,二苯乙烯基联苯二磺酸二钠,对氨基苯甲酸,甲氧基肉桂酸钾,以及它们的混合物。
市场上销售的能够使洗发精得到适当粘度的增稠剂适用于本发明。如果使用的话,那么洗发精中增稠剂的用量应足以使洗发精的Brookfield粘度数值升高到大约500到10,000厘泊之间。适宜的增稠剂的例子包括:分子式V所表示的聚乙二醇单或二酯,
HO-(CH2CH2O)zH
V
其中z是一个大约从3至200的整数;
含有大约16到22个碳原子的脂肪酸;乙氧基多羟基化合物的脂肪酸酯;脂肪酸和甘油的单酯和二酯的乙氧基衍生物;羟烷基纤维素;烷基纤维素;羟烷基烷基纤维素;以及它们的混合物。更明确地讲,适宜的增稠剂有公用性地包括氯化山嵛酸鎓,十六醇,季铵盐46,PG-羟乙基纤维素,氯化椰酸二鎓,多季铵盐6,多季铵盐7,季铵盐18,聚乙二醇-18(PEG-18)丙三醇油酸酯/椰油酸酯,丙烯酸酯/醑剂50丙烯酸酯共聚物,乙基月桂3和丙烯乙二醇的混合物,其从Goldschmidt以商品名“Antil 208”购得,古柯氨基丙基三甲铵乙内酯和甘油基月桂酸酯的混合物,其从Goldschmidt以商品名“Antil HS 60”购得,丙二醇,聚乙二醇-55(PEG-55)和丙二醇油酸酯的混合物,其从Goldschmidt以商品名“Antil 414 liquid”购得,聚乙二醇-150(PEG-150)二硬脂酸酯,其从Stepan CompanyofNorthfield,Illinois或从Comiel,S.p.A.ofBologna,Italy以商品名“PEG 6000 DS”购得,以及这些物质的混合物。
适宜的梳理/湿气梳发剂,不只包括二油酰氨基乙基羟乙基鎓(monium)N-甲硫酸盐,二(大豆酰乙基)羟基乙基鎓(monium)N-甲硫酸盐,氯化羟基乙基二十二氨基丙基二鎓(monium),氯化油酸烷基鎓,多季铵盐47,氯化硬脂酸烷基鎓,氯化三鲸蜡基鎓(monium),以及它们的混合物。
适宜的成膜聚合物包括这样一些物质,其在干燥以后能在头发,皮肤或指甲上产生充分持久的基本上连续的涂层或薄膜。适宜的成膜生聚合物的例子不只包括氯化丙烯基氨基丙基三鎓/丙烯酰胺共聚物;玉米淀粉/丙烯酰胺/丙烯酸钠共聚物;多季铵盐10;多季铵盐47;聚乙烯基甲基/马来酸酐共聚物;苯乙烯/丙烯酸酯共聚物;以及它们的混合物。
市场上出售的在清洗组合物中能够提供水分及调节各种性能的湿润剂适宜在本发明中使用。以组合物总重量为基准,湿润剂的用量可以从大约0%到10%,优选从大约1.5%到7%,最优选从大约2%到5%。适宜的湿润剂的例子不只包括:1)水溶性的液态多羟基化合物,其可以从丙三醇,丙二醇,己二醇,丁二醇,戊二醇,二戊二醇以及它们的混合物中选择;2)分子式VI所示的聚亚烷基二醇:
HO-(R"O)b-H
VI
其中R”是具有大约2到4个碳原子的亚烷基,而且b是从大约1到10的整数,例如聚乙二醇-4(PEG4);3)分子式VII所示的甲基葡萄糖的聚乙二醇醚:
CH3-C6H10O5-(OCH2CH2)c-OH VII
其中c是从大约5到25的整数;
4)尿素;5)果糖;6)葡萄糖;7)蜂蜜;8)乳酸;9)麦芽糖;10)葡糖醛酸钠;以及11)以上物质的混合物。
适宜的氨基酸试剂包括各种不同的蛋白质水解所得到的氨基酸、盐、酯,和它们的酰基衍生物。这种氨基酸试剂的例子不只包括两性氨基酸,例如烷基氨基烷基胺,即十八烷基乙酰基谷氨酸酯,辛酰丝氨酸,辛酰胶原蛋白氨基酸;辛酰角朊(kertain)氨基酸;辛酰豌豆氨基酸;椰子二鎓(monium)羟丙基丝氨酸;玉黍蜀麸质氨基酸;半胱胺酸;谷氨酸;甘氨酸;毛发角蛋白氨基酸;毛发氨基酸,例如天门冬氨酸,苏氨酸,丝氨酸,谷氨酸,果仁糖,甘氨酸,丙氨酸,半双硫丙氨酸,缬氨酸,蛋氨酸,异亮氨酸,亮氨酸,酪氨酸,苯丙氨酸,磺基丙氨酸,赖氨酸,组氨酸,精氨酸,半胱氨酸,色氨酸,瓜氨酸,赖氨酸,丝氨酸,麦氨基酸;以及它们的混合物。
适宜的蛋白质包括这样一些聚合物,它们具有至少10个碳原子的长链,和例如至少约1000的高分子量,而且是由氨基酸通过自缩合而形成的。这样蛋白质的非限制性的例子包括胶原蛋白,脱氧核糖核酸酶,用碘处理的玉黍蜀蛋白质;角蛋白;乳蛋白质;蛋白酶;血清蛋白质;丝蛋白;甜蜜杏仁蛋白;麦芽蛋白质;麦蛋白质;角蛋白质的α-和β-螺旋体;毛发蛋白质,例如中间的细丝蛋白质,高硫蛋白质,超高硫蛋白质,中间的纤维蛋白,高酪氨酸蛋白,高甘氨酸络氨酸蛋白质,三共透明蛋白,以及它们的混合物。
适宜的维生素的例子非限制性地包括复合维生素B;硫胺,烟碱酸,维生素H,泛酸,胆碱,核黄素,维生素B6,维生素B12,吡哆醇(维生素B6),纤维醇,肉毒碱,维生素A,C,D,E,K以及它们的衍生物,例如维生素A的棕榈酸盐和维生素原,例如(即泛酰醇(维生素原B5)和泛酰醇三醋酸酯)以及它们的混合物。
适宜的抗菌剂的例子非限制性地包括枯草杆菌抗生素,红霉素,新霉素,四环素,氯四环素,季铵试剂,例如氯化苯乙鎓和氯化苄烷铵,苯酚以及它们的混合物。
适宜的皮肤软化剂和皮肤润湿液的例子非限制性地包括矿物油,羊毛脂,蔬菜的油,异硬脂酸异十八酯,十二酸甘油酯,甲基葡糖乙基10(gluceth),甲基葡糖乙基20(gluceth)壳聚糖,以及它们的混合物。
适宜的中级头发调节剂的例子非限制性地包括挥发性硅树脂。当使用的时候,挥发性的硅树脂调节剂最好具有在大气压下的沸点要低于220℃。以组合物的总重量为基准,挥发性的硅树脂调节剂的用量从大约0%到3%,例如,从大约0.25%到2.5%或从大约0.5%到1.0%。适宜的挥发性硅树脂的例子非限制性地包括聚二甲基硅氧烷,聚二甲基环硅氧烷,六甲基二硅氧烷,液态环甲基酮,例如聚二甲基环硅氧烷从Dow Corning Corporation of Midland,Michigan以商品名“DC-345”购得,以及它们的混合物。
适宜的头发润湿剂的例子非限制性地包括泛酰醇基乙基醚,植烷三醇,以及它们的混合物。遮光剂的例子非限制性地包括丁基甲氧基二苯甲酰甲烷,辛基甲氧基肉桂酸酯,氧苯酮,八克里纶(octocrylene),辛基水杨酸酯,苯基苯并咪唑磺酸,乙基羟基丙基氨基苯甲酸酯,薄荷醇基(邻)氨基苯甲酸酯,氨基苯甲酸,对甲氧肉桂乙氧乙酯,二乙醇胺甲氧基肉桂酸酯,丙三基氨基苯甲酸,二氧化钛,氧化锌,氧苯酮,二甲胺基苯甲酸戊酯O,红色矿物脂,以及它们的混合物。
一个适宜的使皮肤晒成褐色的试剂的非限制性的例子包括二羟基丙酮。
皮肤增亮剂的例子非限制性地包括对苯二酚,儿茶酚及其衍生物,维生素C及其衍生物,以及它们的混合物。
适宜的杀虫剂(包括昆虫的驱逐剂,防疥疮剂和防虱子处理剂)的例子非限制性地包括苄氯菊酯,除虫菊酯,胡椒基增效醚,imidacloprid,N,N-二乙基甲苯酰胺,其亦涉及主要含有间位异构体,即N,N-二乙基-间-甲苯酰胺,其亦被叫做DEET;分子式VIII所表示的化合物。
其中
R5是一个含有大约1到6个碳原子的直链或支链烷基;
R6是H,甲基或乙基;
R7是一个含有大约1到8个碳原子的直链或支链烷基或烷氧基;和
K是一个-CN或一个-COOR8基团,其中
R8是一个含有大约1到6个碳原子的直链或支链烷基,
天然或合成的拟除虫菊酯,天然的拟除虫菊酯存在于除虫菊中,或Chrysanthernum cinerariaefolium或C coccineum的瓜菊地花萃取物,以及它们的化合物。在分子式VIII所表示的结构里,是乙基-3-(N-丁基乙酰氨基)丙酸酯,R7是一个甲基,R5是一个正丁基,R6是H,K是COOR8以及R8是乙基,其从Merck KgaAofDarmstadt,Germary购得,商品名称为“Insect Repellent 3535”。
抗脚部真菌的一个例子非限制性地包括发癣退。
适宜的脱毛剂的例子非限制性地包括巯基乙酸钙,巯基乙酸镁,巯基乙酸钾,巯基乙酸锶,以及它们的混合物。
适宜的外部止痛剂和局部麻醉剂的例子非限制性地包括苯坐卡因,地布卡因,苯甲醇,樟脑,辣椒素,辣椒,辣椒油性树脂,杜松属焦油,薄荷醇,甲基烟碱酸酯,甲基水杨酸酯,苯酚,间苯二酚,松节油,以及它们的混合物。
适宜的止汗剂和除臭剂的例子非限制性地包括氯氢氧化铝,氯氢氧化铝锆,以及它们的混合物。
适宜的抗刺激剂的例子非限制性地包括樟树,薄荷脑,甲基水杨酸盐,薄荷和丁香油,ichtammol,及其混合物。
适宜的炎症抑制剂的一个例子非限制性地包括氢化可的松。
适宜的防痔疮药品的例子非限制性地包括麻醉剂,例如对氨基苯甲酸乙酯,氢氯化普拉莫星,以及它们的混合物;防腐剂,例如氯化苯乙铵;收敛剂,例如氧化锌,亚没食子酸铋,秘鲁香液,以及它们的混合物;皮肤保护剂,例如鳕鱼肝油,蔬菜油以及它们的混合物。
适宜的化妆品的例子非限制性地包括制造口红,胭脂,腮红,眼线笔,眼影粉,睫毛膏,擦脸粉的成分,以及它们的混合物。
在此处所用的“治疗脱发药物”应包括能够促进头发生长及能够避免掉发的一些试剂。所谓“有效量”,即表示它能有效地处理脱发,以组合物的总重量为基准,其用量范围从大约0.001%到20%,例如最好从大约1%到5%。防脱发适宜的例子包括,但不仅限于,钾系统疏导药或外用血管扩张药物,例如,长压定,氯甲苯噻嗪,以及如美国专利(No:5,244,684)所揭示的N*-氰基-N-(特戊基)-N'-3-吡啶基胍("P-1075")化合物,将此专利引入本发明作为参考;维生素,例如维生素E和维生素C,以及它们的衍生物,维生素E醋酸酯和维生素C棕榈酸酯;激素,例如促红细胞生成素;前列腺素,例如前列腺素E1和前列腺素F2-α;脂防酸,例如油酸;方向利尿剂,例如螺旋内酯甾酮;热休克蛋白质(“HSP”),例如HSP 27和HSP 72;钙系统阻滞剂,例如异搏定HCL,利心平(nifedipine),和硫氮卓酮氨氯吡脒;免疫抑制剂药,例如:环孢子菌素(cyclosporin)和Fk-506;5-α-还原酶抑制剂,例如:溴甲基钠嗪苯甾族化合物;生长素,例如:EGF,IGF和FGF;转换生长素-β;肿瘤坏疽素;非甾类消炎药,例如苯恶洛芬;类视色素,例如:维生素A酸;细胞移动素,例如IL-6,IL-1-α,和IL-1-β;细胞附着分子,例如ICAM;葡糖心脏类皮质激素,例如倍他米松;植物性药材萃取物,例如芦荟,丁香,人参,地黄属,獐牙菜属,甜橙,花椒属植物,盖屋棕榈果新的(锯蝇美洲蒲葵),小金梅草属Hypoxis rooperi,刺荨麻,南瓜籽,和裸麦花粉;其他的植物性药材萃取物包括檀香木(sandlewood),红甜菜根,菊花,迷迭香,牛蒡根和其他头发生长促进剂,其公开在DE 4330597,在此将其全部引用作为参考;顺势疗法的试剂,例如钾五价磷的D2,苦楝树皮indica D2和Joborandi D1;胞质分裂的基因,生长素,和雄性急性斑秃药;抗真菌药,例如酮康唑和elubiol;抗生素,例如链霉素;蛋白质抑制剂,例如环己酰亚胺;乙酰唑胺;苯恶洛芬;可的松;硫氮卓酮;六氯苯;乙内酰脲;硝苯吡啶;青霉素;补骨脂素,异搏定;齐多夫定;α-葡糖基化的(glucosylated)芸香苷,其至少含有下列各种芸香苷之一:栎精,异栎素,hespeddin,柚苷,甲基橘皮苷,类黄酮,和它们的转糖苷化衍生物,以及它们的混合物,所有这些物质全部公开在JP 7002677专利中,在此将其全部引用作为参考。
适宜的用于抑制毛发生长助剂的例子包括:例如胰岛素的丝氨酸蛋白酶,例如α-生育酚(维生素E)的维生素及其衍生物,例如生育酚醋酸酯和生育酚棕榈酸酯;抗肿瘤助剂,例如阿霉素,环磷酰胺,甲川氯,氨甲蝶呤,氟尿嘧啶,长春新碱,道诺霉素,博来霉素,以及羟基尿素;抗凝血剂,例如肝磷脂,类肝素,coumaerins,detran和2,3-二氢-1,3-茚二酮;抗甲腺药,例如碘,硫脲嘧啶和甲亢平;锂和碳酸锂;干扰素,如干扰素-α,干扰素-α-2a和干扰素-α-2b;类维生素A,例如视黄醇(维生素A),异维甲酸;糖皮质激素,例如倍他米松,以及肾上腺皮质类固醇;抗高脂血药,例如三苯乙醇和安妥明;铊;水银;丙硫咪唑;别嘌呤醇;乙胺碘呋酮;安非他明;男性荷尔蒙;溴麦角环肽;丁酰苯;立痛定;消胆胺;甲腈咪胺;安妥明;炔羟雄烯异唑;去郁敏;羟乙氧拉嗪;乙胺丁醇;etionamide;fluoxetine;庆大霉素;黄金盐;乙内酰脲;布洛芬;impramine;免疫球蛋白;2,3-二氢-1,3-茚二酮;消炎痛;intraconazole;levadopa;马普替标;二甲麦角新碱;美多心安;甲吡酮;萘羟心安;烟碱酸;硫氰酸钾;心得安;pyridostimine;水杨酸盐;柳氮磺胺吡啶;terfenadine;甲砜氯霉素;硫脲嘧啶;三甲双酮;troparanol;2-丙基戊酸,以及它们的混合物。以组合物的总重量为基准,组合物中含有从大约0.001%至大约20%,例如从大约0.01%至大约5%的头发生长抑制剂。
适宜的抗老化试剂例子包括,但并不仅限于,无机遮光剂,例如二氧化钛和氧化锌;有机遮光剂,例如甲基肉桂酸辛酯及其衍生物;类维生素A;维生素,例如:维生素E,维生素A,维生素C,维生素B和它们的衍生物,例如维生素E的醋酸盐,维生素C的棕榈酸盐,及其同类物;抗氧剂,包括β-胡萝卜素,α-羟基酸,例如:乙醇酸,柠檬酸,乳酸,苹果酸,扁桃酸,维生素C,α-羟基酪酸,α-羟基异酪酸,α-羟基异己酸,阿卓乳酸,α-羟基异颉草酸,丙酮酸乙酯,半乳糖醛酸,glucopehtonic酸,glucopheptonol,4-内酯,葡糖酸,葡糖酸内脂,葡糖醛酸,葡萄糖醛内酯,羟基乙酸,异丙基丙酮酸酯,甲基丙酮酸酯,粘酸,丙酮酸,砂糖酸,葡糖二酸-1,4-内酯,酒石酸,和羟基丙二酸;β-羟基酸,例如:β-羟基酪酸,β-苯基乳酸,β-苯基丙酮酸;植物性药材萃取物,例如:绿茶,大豆,牛奶,蓟,藻类,芦荟,当归,苦橘,咖啡,黄连,柚子,hoellen,金银花,戳泪滴,紫草,桑树,牡丹,puerarua,nice,红花,以及它们的混合物。以组合物的总重量为基准,抗老化剂适宜的量从大约0.01%到大约10%,例如从大约0.04%到大约5%。
适宜的抗痤疮试剂的例子包括,但并不仅限于,外用的类维生素A(维生素A酸,异维生素A酸,motretinide,adapalene,tazarotene,杜鹃花酸,维生素A);水杨酸;过氧化苯甲酰;间苯二酚;抗生素,例如:四环素及其异构体;美国的一种抗生素(erythromycin);抗兴奋药,例如:布洛芬,萘普生,hetprofen;药用植物萃取物,例如:赤扬皮,山金车花,艾属毛细管,细辛根,马兜铃属植物,金盏草,甘菊,蛇床属,紫草科植物,茴香,虫瘿rhois,山楂,鱼腥草,金丝桃属植物,枣,无翼鸟,甘草,木兰,橄榄,薄荷,黄蘖,琴柱草,赤竹属albo-marginata;咪唑,例如:ketoconazole和elubiol的,和那些被Gollnick,H.等在196(1)Dermatology Sebaceous Glands,Acne and Related Disorders.119-157(1998)中所描述的物质,以及它们的混合物,将其全部引入作为参考。以清洗组合物的总重量为基准,抗痤疮剂的用量从大约0.01%到10%,例如从大约0.04%到大约5%。
以清洗组合物的总重量为基准,适宜有效量的脱色剂的含量从大约0.01%到大约10%,例如从大约0.04%到大约5%。适宜的脱色剂的例子包括,但并不仅限于,类维生素A,例如:视黄醇;曲酸及其衍生物,例如:曲酸的二棕榈酸盐;对苯二酚及其衍生物,例如:对苯二酚葡糖苷;transexamic酸;维生素类,例如:烟酸,维生素C及其衍生物;壬二酸;placertia;甘草;萃取物,例如:甘菊,绿茶以及它们的混合物。
在此所用的“头皮屑治疗剂”,“脂溢性皮炎治疗剂”或“牛皮癣治疗剂”分别将包括这样一些试剂,其能够分别治疗头皮屑,脂溢性皮炎,和牛皮癣的症状及/或疾病。所谓“有效量”是指其含量对这些疾病和/或症状的治疗有效。以清洗组合物的总重量为基准,其优选的含量范围可以从大约0.001%到大约10%,例如从大约0.01%到大约5%。治疗头皮屑,脂溢性皮炎和牛皮癣及其所伴随的症状的有效药剂的例子包括,但并不仅限于,羟基吡啶硫酮锌,页岩油及其衍生物,例如:磺化的页岩油,硫化硒,硫磺;水杨酸;煤焦油;聚烯吡酮碘,咪唑例如氧代康唑(ketoconazole),二氯苯基咪唑二氧代(imidazolodioxalan),其在Janssen Pharmaceutica,N.V.处出售,商品名称为“Elubiol”,克霉唑,依曲康唑(itraconazole),咪康唑(miconazote),克来霉唑(climbazole),tioconazole(-azole唑),长须海葵黄质(sulconazole),丁氧康唑(butoconazole),氟康唑(fluconazole),咪康唑(miconazole)亚硝酸盐和任何可能的立体异构体和它们的衍生物,例如:蒽三酚;piroctone乙醇胺(Octopirox);硫化硒;ciclopirox乙醇胺;抗牛皮癣药剂,例如维他命D类似物,如钙钋三醇,钙三醇和钽钙三醇维生素A类似物,如维生素A的酯,例如维生素A棕榈酸酯,类维生素A,维生素A和视黄酸;皮质类固醇,例如氢化可的松,去氢氯氟美松,丁酸盐,去氢氯氟美松丙酸酯以及它们的混合物。
举例来说,清洗组合物中助剂的含量取决于使用者对使用结果的期望值及敏感程度。如果要表示其含量的话,这些助剂在清洗组合物中的量占清洗组合物总重量的比例最好从大约0.001%到大约20%,例如从大约0.001%到大约10%或从大约0.001%到大约5%。
每种助剂的温和性将取决于所选择的助剂和所使用助剂的量。因此,一般来讲,在本发明的实施方案中温和性受到特别的关注,本组合物可以省略助剂或选择低含量的助剂。同样地,助剂对泡沫剂的作用也将会取决于所选择的助剂的种类和所使用的助剂的量。因此,一般来讲,在各实施方案中产生优质的泡沫受到特别的关注,本组合物可以省略助剂或使用其低的含量。
本发明组合物的pH值将会取决于所选择的助剂的种类和所需要的产品类型,例如:洗发香波,洗涤剂,等等。然而,pH值典型地维持在从大约3到大约7.5的范围,例如,从大约5.5到大约7.0。对于洗发组合物来说,所用的pH值典型地从大约5.5到大约7.5。具有从大约3到大约5的pH的本发明的组合物适用于将多种皮肤护理助剂供给到皮肤上,这些皮肤护理助剂包括,但不仅限于α-和β-羟基酸,例如:水杨酸,羟基乙酸,乳酸,以及它们的混合物。具有大约为7或更高pH值的本发明的组合物适用于将多种例如氯化苄烷铵和氯化苄甲乙氧铵的四元抗菌助剂供给到皮肤上。
以上所说的清洗组合物可以通过将所需要的成分在适宜的容器中,在环境条件下使其混合来制备,制备时可采用本领域熟知的任何常规的混合设备,例如:使用螺旋桨式机械搅拌,浆形棒等。尽管对混合的次序不很严格,但是最好将某些成份预先混合,例如在将芳香性物质和非离子表面活性剂添加到主要的混合物中之前,先将其预混合。
本发明的组合物最好用于洗发香波、洗涤剂、浴液、凝胶、洗液、面霜及起清洁作用的类似品中。在一个实施方案中,组合物用于起泡浴液中,正如美国专利(专利号:4,650,661;4,666,707;和4,002,758)所描述的那些组合物一样,在此将其引入作为参考。
本发明的组合物可以以现有已知的任何个人的清洗手段应用于人体,例如:擦拭,毛巾,网状或有孔的薄膜,厚圆垫,海绵,刷子及其类似物品。在一个实施方案中,本组合物可以与一种或几种这样的工具放在一起在市场上成套销售。这些器具可以填充适宜的皮肤护理剂以潮湿状态一起包装,例如湿纸巾。可以通过将器具浸泡在组合物中,将组合物喷洒在器具上,以及其他已知的方法将本发明的组合物负载在器具上。
作为可替代的方法,湿的器具可以经过采用加热设备,真空干燥机,或其他现有的已知手段使其变成干的器具,例如干的纸巾。作为可替代的方法,本发明的组合物可以以浓缩的形式应用于器具上,以提供干燥的制品。这些干燥的制品可以以干燥的状态销售以满足消费者,这些消费者在准备使用的时侯才将干燥的商品用水弄湿。
本发明的组合物对眼睛的刺激程度低。所谓“对眼睛的刺激程度低”,意味着此组合物对眼睛的刺激程度不比纯净的消过毒的水更严重。
下面提出的一些例子将进一步说明本发明的性质和完成的方式。然而,本发明并不能被认为仅限于这些例子所描述的细节。
实施例
在下面的各实施例中使用下列测试方法:
人体眼睛的刺激试验:这是双盲、随机、二单元研究,测试材料应用一次。测试样品被稀释成10%的溶液,并且将其维持在37-38℃,将此测试材料逐渐滴加到测试者的一只眼中,将消过毒的纯净水逐渐滴加到测试者的另一只眼中。此项研究需要10名测试者。
按照随机的次序对测试者进行测试,而且指定哪种物质对哪只眼进行滴加以及滴加的材料也是以随机的方式进行。将一滴适当的测试液慢慢地滴加到测试者的第一只眼,然后将消过毒的水慢慢地滴加到第二只眼。对于每一个测试材料均使用新的消过毒的一次性点眼药器,而且在用于测试者的一只眼睛以后即处理掉。所有的慢慢滴加材料的工作均由调研员或训练有素的技术员完成。对于每一只眼均使用单独的纸巾以吸净从各自眼睛中流出的眼泪。
在30秒内,或尽可能快地在滴加测试材料之后,询问测试者,利用下列标准对他们的眼睛受刺激的感觉进行分级:0=在正常限度之内;1=温和的,非常轻微的刺激;2=中等刺激;和3=严重刺激。在滴加测试材料1/4小时和1个小时以后,再一次询问测试者,对眼睛的的刺激进行分级。
实施例1:清洗剂的制备
制备三个各自独立的样品,其所使用的材料列于表1:
表1
CTFA名称 | #1* | #2* | #3* | #4* |
癸基葡糖苷 | 3.0 | 3.0 | 3.0 | 3.6 |
椰子酰氨基丙基甜菜碱 | 3.0 | 6.0 | - | 4.7 |
月桂两性双乙酸二钠 | 3.0 | - | 6.0 | 0.7 |
*以重量百分比表示
每一个样品都是通过将适量的有效的表面活性剂添加到水中的方法独立地制备,这样样品的总量为100%。然后对每种溶液进行搅拌直至得到均一的清液
泡沫稳定性的评价是采用Airspray袖珍型发泡机0.4cc泵来完成的。该泵能够挤压出衡量的液体而且能使其与空气混合,因此能够产生足够的能量来制造泡沫。随着时间,泡沫最后破裂。然而,密集的,稳定的泡沫比松散的、不稳定的泡沫将会较长时间的保持它的泡沫结构。采用这种泡沫测试的程序如下所示:
1)每个样品被插入一个独立的袖珍发泡机中,然后使泵运行一个冲程将样品输送到一个多孔的基质上,此基质可以吸排液体。
2)对泵出的样品进行最初的、视觉评价,将结果分为1-10十个等级。“10”级表明非常密集的、乳脂状的高质量的泡沫,而“1”级表明水完全排干的泡沫的残体。
3)随着泡沫逐渐地消退,对泵出的样品定期进行评价。
结果如表2所示。
表2
时间(分) | #1 | #2 | #3 | #4 |
1 | 10 | 10 | 10 | 10 |
2 | 10 | 9 | 9 | 10 |
3 | 10 | 7 | 7 | 9 |
4 | 10 | 3 | 2 | 9 |
5 | 8 | 1 | 1 | 7 |
10 | 8 | 1 | 1 | 7 |
14 | 6 | 1 | 1 | 4 |
15 | 4 | 1 | 1 | 2 |
从上面的数据可以看出,本发明的组合物可以提供持续时间长的稳定的泡沫,这些泡沫密集、乳脂状并且具有高质量。尤其由样品1和4所显示的,稳定的泡沫近似地保持了它的初始的泡沫高度和质量,即保持了白色/彩色,非常密集,在比三分钟还要长的时间里并不消退,并且这些稳定的泡沫所持续的时间是作为对照清洗剂所产生的泡沫的两倍。
实施例2:带有调节剂的清洗组合物的制备
制备一种具有润湿作用的清洗组合物,其所使用的材料和百分含量列于下面的表3中:
表3
商品名/供应商 | INCl名称 | %W/W |
Plantaren 2000/Cognis Corporation | 癸基葡糖苷 | 6.0 |
Lamesofe P065/Cognis Corporation | 3.00 | |
水 | 1.05 | |
椰子葡糖苷 | 1.05 | |
油酸甘油酯 | 0.9 | |
PEG 6000 DS/Stepan Company | 聚乙二醇150(PEG 150)二硬脂酸酯 | 1.4 |
Atlas G4280/Uniqema Company | POE 80山梨聚糖月桂酸酯 | 5.0 |
水 | 去离子水 | 59.67 |
聚合物JR/Amerchol Corporation | 多季铵盐10 | 0.12 |
Glucquat 125/Amerchol Corporation | 月桂基甲基ghceth-10/氯化羟基丙基二蝓 | 1.00 |
Tegobetaine L-7(30%)/Goldschmidt ChemicalCorpomtion | 椰子酰氨基丙基甜菜碱 | 12.00 |
Monateric 949J/Uniqema | 月桂两性双乙酸二钠 | 2.00 |
Polyox WSR-205/Amerchol | 聚乙二醇14M(PEG-14-M) | 0.10 |
公司 | ||
甘油/Cognis Corporation | 甘油 | 0.50 |
Cromollient SCE/Croda Inc. | Di-PPG-Myreth-10-Adipate | 1.0 |
Lipovol J/Lipo Chemical Inc. | 加州希蒙得木油 | 0.1 |
Drakeol 7/Penreco | 矿物油 | 0.10 |
香料 | 香料 | 0.50 |
Dowcil 200/Dow Chemical Company | 季铵盐15 | 0.05 |
Versene100XL/DowChemical Company | 乙二胺四乙酸四钠 | 0.46 |
Euperlan PK 3000/Cognis Corporation | 2.00 | |
椰子氨基丙基甜菜碱 | ||
二硬脂酸乙二醇酯 | ||
Laureth-4 | ||
柠檬酸(20%) | 柠檬酸 | 按需使用 |
制备了下列预混合物:
预混合物1:将聚乙二醇-14M(PEG-14M)和甘油在一个独立的容器中在环境条件下混合。
预混合物2:将双-聚丙二醇-2-乙氧基(myreth)-10-己二酸酯,矿物油,西蒙得油在一个独立的容器中在环境条件下混合。
预混合物3:将香料和1份的聚氧乙烯醚-80(POE-80)山梨聚糖月桂酸酯在一个独立的容器中在环境条件下混合。
在这个工艺中各组分有效成分的重量以其占所制备的清洗组合物的总重量的百分比表示。
将癸基的糖苷,椰子糖苷和丙三基油酸酯在一个独立的容器中在环境条件下混合,直到得到澄清溶液。然后将此溶液加热到约50℃到55℃,同时持续搅拌。将聚乙二醇150二硬脂酸脂加入溶液中,同时在恒温下搅拌直到聚乙二醇150二硬脂酸酯溶解在溶液当中。当所制得的溶液冷却到40℃时,伴随着搅拌连续地加入下列物质,在加入下列物质之前溶液是均一的,4份的聚氧乙烯醚-80山梨聚糖醇月桂酸酯:59.67份水;多季铵盐-10;月桂基甲基(lauryl methyl)gluceth-10;氯化羟基丙基二鎓;椰子酰氨基丙基甜菜碱;月桂两性双乙酸二钠;聚乙二醇-14M/丙三醇预混合物;和双-聚丙二醇-2-myreth-10-己二酸酯/矿物油/西蒙得油预混合物。
将制得的混合物冷却到大约40℃以后,依次加入下列成分,在加入下列各项成分之前溶液是均一的:香料/聚氧乙烯醚-80山梨聚糖月桂酸酯预混合物,季铵盐-15,乙二胺四乙酸四钠,乙二醇二硬脂酸酯和laureth-4。在加入氯化钠之后将所得溶液的pH值用柠檬酸调节到大约6.8。然后将剩余的水加入溶液中,同时不断搅拌直到溶液呈均一状态。所制得溶液的粘度用Brookfield DV-1+粘度计使用6转/每分的速度和#2纺锤测量为1300厘泊。
实施例3:眼睛的刺激测试
用实施例2所制得的组合物进行人体的眼睛刺激测试。研究的结果如表4所示。
表4
这个例子表明本发明的组合物不比消过毒的纯净水对眼睛的刺激更严重。
样品 | 对眼睛刺激的等级 |
实施例2的组合物 | 0 |
Claims (10)
1.一种清洗组合物,包含:
至少一种糖苷类的非离子表面活性剂;
至少一种甜菜碱的表面活性剂;和
至少一种两性的表面活性剂,该组合物基本上上并不含有阴离子表面活性剂。
2.根据权利要求1所述的组合物,其中组合物对眼睛的刺激程度低,并且能产生持续稳定的泡沫。
3.根据权利要求1所述的组合物,其中糖苷类的非离子表面活性剂是选自椰子糖苷,辛基糖苷,癸基糖苷,月桂基糖苷以及它们的混合物。
4.根据权利要求3所述的组合物,其中糖苷类非离子表面活性剂的用量,以组合物的总重量来计,其范围从大约1%到大约10%。
5.根据权利要求1所述的组合物,其中糖苷类非离子表面活性剂是癸基糖苷,以组合物的总重量来计,其用量范围从大约1%到大约10%;甜菜碱表面活性剂是椰子酰氨基丙基甜菜碱,以组合物的总重量来计,其用量范围从大约1%到大约10%;两性表面活性剂是月桂两性二乙酸酯,以组合物的总重量来计,其用量范围从大约1%到大约10%。
6.根据权利要求1所述的组合物,其中糖苷类非离子表面活性剂的量对两性表面活性剂和甜菜碱表面活性剂的总和的比例范围从大约1∶4到大约1.5∶1。
7.根据权利要求1所述的组合物,进一步含有从大约0.01%到大约5%的阳离子调节聚合物;从大约0.1%到大约5%的软化剂,这些软化剂选自二酯,三酯,或者它们的混合物;以及从大约0.1%到大约10%的单酯软化剂。
8.根据权利要求1所述的组合物,进一步包含有助剂。
9.如权利要求1所述的组合物在选自:纸巾,毛巾,带网眼或有孔的薄膜,厚圆垫,海绵和刷子的工具中的用途。
10.一种成套用品,包括根据权利要求1所述的组合物和选自纸巾,毛巾,带网眼或有孔的薄膜,厚圆垫,海绵和刷子的工具。
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/931,703 US6998372B2 (en) | 2001-08-16 | 2001-08-16 | Moisturizing detergent compositions |
US09/931,703 | 2001-08-16 | ||
US09/954,335 | 2001-09-17 | ||
US09/954,335 US20030069148A1 (en) | 2001-08-16 | 2001-09-17 | Mild cleansing composition having stable foam |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1407077A true CN1407077A (zh) | 2003-04-02 |
Family
ID=27130014
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 02131518 Pending CN1407077A (zh) | 2001-08-16 | 2002-08-16 | 温和的具有稳定泡沫的清洁组合物 |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1284135A3 (zh) |
JP (1) | JP2003206499A (zh) |
CN (1) | CN1407077A (zh) |
BR (1) | BR0203352A (zh) |
CA (1) | CA2398222A1 (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1307486C (zh) * | 2004-12-20 | 2007-03-28 | 西安交通大学 | 聚二甲基硅氧烷微流控芯片复型光固化树脂模具制作方法 |
CN101432413B (zh) * | 2006-04-28 | 2011-03-09 | 化工产品开发公司Seppic | 用于改进局部应用的清洁和/或发泡制剂的发泡性能的新方法 |
CN104277933A (zh) * | 2014-09-28 | 2015-01-14 | 青岛康合伟业商贸有限公司 | 一种适宜敏感肌人群使用的洗洁精 |
CN105779176A (zh) * | 2014-12-19 | 2016-07-20 | 天津海滨圣地钢铁有限公司 | 一种环保厨房油污分解剂 |
CN111235530A (zh) * | 2020-01-15 | 2020-06-05 | 董翠萍 | 一种用于铝型材加工的真空喷镀处理工艺 |
CN111743478A (zh) * | 2020-06-15 | 2020-10-09 | 天津市艳胜工贸有限公司 | 一种kbs植物萃取湿巾 |
CN112094699A (zh) * | 2020-09-27 | 2020-12-18 | 广西壮族自治区林业科学研究院 | 一种樟树纯露的提取方法 |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10258395A1 (de) * | 2002-12-12 | 2004-06-24 | Henkel Kgaa | Reinigungstücher zur Reinigung keratinischer Fasern |
US20050276827A1 (en) * | 2004-06-14 | 2005-12-15 | Macedo Filomena A | Personal cleansing kit and method having fibrous implement with expiration indicia |
DE102005028622A1 (de) * | 2005-06-20 | 2007-01-04 | Henkel Kgaa | Haarpflegemittel |
JP4825516B2 (ja) * | 2005-12-27 | 2011-11-30 | 花王株式会社 | 洗浄剤組成物 |
EP1975224A1 (en) * | 2007-03-30 | 2008-10-01 | Johnson & Johnson Consumer France SAS | Mild, foaming cleansing composition |
DE102010001360A1 (de) * | 2009-11-18 | 2011-05-19 | Henkel Ag & Co. Kgaa | Schaumförmige Färbemittel |
EP3384896B1 (en) | 2010-07-19 | 2020-10-14 | Colgate-Palmolive Company | Cleansing composition with 4-oxovaleric acid and leuconostoc/radish root ferment filtrate |
US20160089322A1 (en) * | 2014-09-29 | 2016-03-31 | Johnson & Johnson Consumer Inc. | Cleansing Compositions |
EP3334400A1 (en) * | 2015-08-14 | 2018-06-20 | L'oreal | Cosmetic composition comprising a cationic surfactant, a fatty alcohol, an amphoteric surfactant, a starch derivative, and a cationic conditioning polymer |
WO2019113813A1 (en) * | 2017-12-13 | 2019-06-20 | Beiersdorf Daily Chemical (Wuhan) Co. Ltd. | A hair cleansing composition |
KR102556847B1 (ko) * | 2022-11-29 | 2023-07-18 | 주식회사 더블유에스아이 | 동물용 세정제 조성물 및 이를 포함하는 키트 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19539877C2 (de) * | 1995-10-26 | 1998-07-23 | Henkel Kgaa | Kosmetische und pharmazeutische Emulsionen |
US6090773A (en) * | 1996-01-29 | 2000-07-18 | Johnson & Johnson Consumer Products, Inc. | Personal cleansing |
GB9612595D0 (en) * | 1996-06-15 | 1996-08-21 | Smithkline Beecham Plc | Composition |
WO1999019438A1 (en) * | 1997-10-15 | 1999-04-22 | Stepan Company | High foaming detergent composition having non-ionic surfactant base |
US6045145A (en) * | 1999-07-19 | 2000-04-04 | Lan; Red | Stroller with detachable auxiliary seat |
-
2002
- 2002-08-15 EP EP02255693A patent/EP1284135A3/en not_active Withdrawn
- 2002-08-15 CA CA 2398222 patent/CA2398222A1/en not_active Abandoned
- 2002-08-15 JP JP2002237047A patent/JP2003206499A/ja active Pending
- 2002-08-16 CN CN 02131518 patent/CN1407077A/zh active Pending
- 2002-08-16 BR BR0203352A patent/BR0203352A/pt not_active Application Discontinuation
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1307486C (zh) * | 2004-12-20 | 2007-03-28 | 西安交通大学 | 聚二甲基硅氧烷微流控芯片复型光固化树脂模具制作方法 |
CN101432413B (zh) * | 2006-04-28 | 2011-03-09 | 化工产品开发公司Seppic | 用于改进局部应用的清洁和/或发泡制剂的发泡性能的新方法 |
CN104277933A (zh) * | 2014-09-28 | 2015-01-14 | 青岛康合伟业商贸有限公司 | 一种适宜敏感肌人群使用的洗洁精 |
CN105779176A (zh) * | 2014-12-19 | 2016-07-20 | 天津海滨圣地钢铁有限公司 | 一种环保厨房油污分解剂 |
CN111235530A (zh) * | 2020-01-15 | 2020-06-05 | 董翠萍 | 一种用于铝型材加工的真空喷镀处理工艺 |
CN111743478A (zh) * | 2020-06-15 | 2020-10-09 | 天津市艳胜工贸有限公司 | 一种kbs植物萃取湿巾 |
CN112094699A (zh) * | 2020-09-27 | 2020-12-18 | 广西壮族自治区林业科学研究院 | 一种樟树纯露的提取方法 |
CN112094699B (zh) * | 2020-09-27 | 2023-03-28 | 广西壮族自治区林业科学研究院 | 一种樟树纯露的提取方法 |
Also Published As
Publication number | Publication date |
---|---|
CA2398222A1 (en) | 2003-02-16 |
BR0203352A (pt) | 2003-05-27 |
EP1284135A2 (en) | 2003-02-19 |
JP2003206499A (ja) | 2003-07-22 |
EP1284135A3 (en) | 2003-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100766731B1 (ko) | 침착, 컨디셔닝 및 유연화 능력이 강화된 신규한 세정제 조성물 | |
US20030069148A1 (en) | Mild cleansing composition having stable foam | |
TWI237569B (en) | Foaming oil gel compositions | |
CN1407077A (zh) | 温和的具有稳定泡沫的清洁组合物 | |
US7262158B1 (en) | Cleansing compositions comprising a liquid silicone and ester mixture | |
JPH05506873A (ja) | クレンジング製品 | |
US20040167046A1 (en) | Cleansing compositions | |
EP1174122B1 (fr) | Composition cosmétique de nettoyage | |
CN1929812A (zh) | 个人清洁组合物 | |
KR20010049428A (ko) | 신규 국소 제형 | |
MXPA00005050A (es) | Limpiador cutaneo espumante, acuoso, claro, ultrasuave. | |
CN106999384B (zh) | 清洁组合物 | |
JP2003183153A (ja) | 老化防止活性剤を含有する皮膚洗剤 | |
US10780029B2 (en) | Triphasic cleansing composition | |
CN101080212A (zh) | 包含聚合乳化剂的清洁组合物及其使用方法 | |
JP7217925B2 (ja) | 皮膚洗浄剤組成物 | |
CN1227592A (zh) | 清洁组合物 | |
KR930007227B1 (ko) | 세제와 로션 성분이 균형을 이룬 에멀젼 형태의 중성 액체 피부 세정 조성물 | |
JP7558743B2 (ja) | 皮膚洗浄剤組成物 | |
CN1227591A (zh) | 清洁组合物 | |
JP2024059310A (ja) | 変色抑制剤及びそれを用いた皮膚洗浄剤組成物 | |
CN116916878A (zh) | 包含椰油酰胺丙基甜菜碱和至少一种脂肪酸的组合物 | |
JP2023027812A (ja) | 皮膚洗浄剤組成物 | |
AU2007201504A1 (en) | Cleansing compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |